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Abstract
Suspensions of magnetic nanoparticles offer diverse opportunities for technology innovation, 
spanning a large number of industry sectors from imaging and actuation based applications 
in biomedicine and biotechnology, through large-scale environmental remediation uses such 
as water purification, to engineering-based applications such as position-controlled lubricants 
and soaps. Continuous advances in their manufacture have produced an ever-growing range 
of products, each with their own unique properties. At the same time, the characterisation of 
magnetic nanoparticles is often complex, and expert knowledge is needed to correctly interpret 
the measurement data. In many cases, the stringent requirements of the end-user technologies 
dictate that magnetic nanoparticle products should be clearly defined, well characterised, 
consistent and safe; or to put it another way—standardised. The aims of this document are 
to outline the concepts and terminology necessary for discussion of magnetic nanoparticles, 
to examine the current state-of-the-art in characterisation methods necessary for the most 
prominent applications of magnetic nanoparticle suspensions, to suggest a possible structure 
for the future development of standardisation within the field, and to identify areas and topics 
which deserve to be the focus of future work items. We discuss potential roadmaps for the 
future standardisation of this developing industry, and the likely challenges to be encountered 
along the way.
Keywords: magnetic colloids, magnetic nanoparticles, ferrofluid, nanoparticle characterisaton, 
standardisation, roadmap, magnetic particle imaging
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1. Introduction
Magnetic nanoparticles (MNPs) in liquid suspensions are rap-
idly being implemented in a diverse set of new and emerging 
technologies [1–6]. Key technology areas include the use of 
MNPs as biomedical imaging agents; as functionalised parti-
cles for in vitro enrichment of cells, viruses, proteins or nucleic 
acids; as magnetic slurries for the adsorption of hazardous 
materials or water desalination; and as magnetic oils for use 
in vacuum seals, lubricants, and loudspeakers. Many of these 
applications impose stringent requirements on the MNPs to be 
used, in order to ensure correct functioning and safety [7], but 
each application requires its own specific characteristics, and 
the appropriate characterisation parameters vary accordingly. 
To date, a huge variety of compositions, structures and mor-
phologies of MNPs have been developed to meet established 
industry needs, while at the same time MNPs continue to be 
the subject of cutting edge research and development (R&D) 
aimed at meeting new and emerging industry needs.
Alongside this concerted industry-focused R&D effort, 
there is clearly a need for the development of appropriate and 
robust standards relating to the characterisation of MNPs in 
liquid suspensions. A standard provides an agreement on the 
current scientific state-of-the-art within a topic, and guide-
lines on implementing this knowledge for the optimisation of 
manufacturing, measurement, analysis and safety. Best prac-
tice guides provide information and guidance on technical 
methodologies that have been accepted as being superior to 
their competing alternatives. Standard operating procedures 
contain specific step-by-step instructions on how the carry out 
processes in order to achieve optimal quality, and comply with 
regulations. Both best practice guides, and standard operating 
procedures may be incorporated into standards documents. 
While the creation of new standards is driven by the needs of 
industry, their development is a task for science. A recently 
published book discusses the wider topics of metrology and 
standardisation for the field of nanotechnology as a whole [8] 
and provides an introduction to the standardisation of MNPs, 
a subject which we examine in detail here.
It is in this context that we provide here an overview of 
the current state-of-the-art in the science of magnetic nano-
particles, and the future tasks and challenges we face in order 
to reach the complete standardisation of MNP products. 
Throughout the document, we highlight many of the open 
questions and unsolved problems which currently inhibit pro-
gress within the sector. These represent significant opportuni-
ties for future research projects, and are intended to provide 
an overview or roadmap of major topics which should be 
addressed within the coming years, In part, this article rep-
resents some of the conclusions that have been reached over 
the last four years by a broad consortium of academic labora-
tories, national metrology institutes and industrial collabora-
tors who have been working together under the auspices of 
the European Commission’s Seventh Framework Programme 
project ‘NanoMag: Nanometrology standardisation methods 
for magnetic nanoparticles’ [9]. The document presented here 
is intended to act as a precursor to the future development of 
MNP standards.
The review is structured as follows. Initially, we provide 
an overview of the potential standardisation routes for MNPs 
which might be implemented. We then volunteer a possible 
framework for future standards documents based on both 
the constraints of the subject matter, and the requirements 
for document development stipulated by the International 
Organization for Standardization (ISO). To conclude, we pre-
sent an overview of the standardisation work which is cur-
rently underway in the MNP field, discuss additional tasks 
which need to be undertaken, and provide a roadmap for the 
future of the topic.
2. Routes towards standardisation of MNP 
suspensions
MNP suspensions form a vast and diverse topic which spans 
a huge variety of industries, each with highly specialised 
requirements. Specific terminology is required to describe the 
unique aspects of MNPs, many of which have yet to achieve 
universal definitions in the literature. In addition, there are a 
multitude of techniques for both the synthesis and characteri-
sation of MNP suspensions. A particular selection of these 
techniques and definitions will be required for a specific prod-
uct; this is dictated by the application for which it is destined.
Furthermore, our understanding of the health and safety 
implications for nanomaterials, from production and release 
criteria through to storage requirements and disposal meth-
ods, is still developing. This is because there are fundamental 
physical characteristics and factors applying to nanoparticles, 
which are distinct from those applicable to the same materials 
when they are in the bulk form. As such, the very large amount 
of accumulated knowledge that exists for bulk materials can-
not simply be applied to the nanoparticulate state, and new 
standards are needed.
2.1. Standardisation methods
There are two conventional routes towards the standardisation 
of materials, which in principle might be applicable to the case 
of MNPs in liquid suspensions. These are: (1) the adoption of 
standardised synthesis processes intended to result in particles 
with predictable and reproducible properties; and (2) the post-
synthesis characterisation of MNPs in order to establish the 
specific characteristics of a batch of particles after manufac-
ture [10]. We conclude that the standardisation of characteri-
sation methods is the approach best suited to the MNP sector. 
Based on this, we propose a framework for the organisation of 
future standards documents in order to provide coverage for 
this varied and complex area. The proposed structure is based 
on the compilation of portmanteau documentation covering 
vocabulary/definitions; sampling; measurements; labelling; 
and applications.
2.1.1. Standardisation of synthesis methods. It has long been 
noted that batch-to-batch reproducibility in nanoparticle syn-
thesis is a significant challenge, and a key obstacle to the devel-
opment of marketable products. Variations in particle output 
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are commonly the result of either the uncontrollable pres-
ence (or variation) of contaminants in raw materials, and/or 
the uncontrollable variation in production process param-
eters. Even with access to detailed procedural instructions, 
issues with reproducibility become amplified when trying 
to  reproduce synthesis processes in different laboratories. 
 Furthermore, the problem of reproducibility in synthesis 
increases with the batch size under production [11]. As a 
result, at present the standardisation of synthesis methods 
remains a significant challenge.
A further consideration is the large variety of synthesis 
routes which are available for producing MNPs. The precise 
details of individual synthesis techniques are frequently kept 
secret in order to protect the intellectual property of manufac-
turers, and prevent competitors from copying their products. 
Due to the reluctance of the MNP industry to share the precise 
details of individual manufacturing processes, it is unrealistic 
to attempt to create global standards for them. This, coupled 
with the complexities that would be involves in drawing up 
standardised techniques for every possible MNP synthesis 
route, mean that we do not regard the standardisation of syn-
thesis methods as the best option.
In this review, we therefore choose to concentrate primar-
ily on the standardisation of characterisation methods, rather 
than on synthesis procedures. It should be noted, however, 
that a small number of published standards do exist pertain-
ing to vocabulary and processes relevant to MNP production 
[12–22], in addition, some standards of relevance are cur-
rently under preparation at the International Electrotechnical 
Commission [23]. The study of the exact parameters which 
dictate variations in nanoparticle synthesis, and the quest for 
reproducibility remain ongoing topics in front-line research 
[24]. The reproducible synthesis of identical MNPs in differ-
ent labs remains a scientific goal. With greater understand-
ing of the interplay between the important limiting factors, 
standards for MNP synthesis can be expected to develop in 
the future.
2.1.2. Standardisation of characterisation techniques. As the 
standardisation of MNPs synthesis requires significant R&D 
advances, post-synthesis characterisation promises a faster 
and in particular more reliable route towards achieving the 
harmonisation of MNP products. A vast variety of charac-
terisation techniques exist, probing both magnetic and non-
magnetic parameters. In many cases, multiple measurement 
techniques are capable of probing the same parameter through 
alternative means [25].
It is notable that while several standards have been pub-
lished relating to the characterisation of non-magnetic proper-
ties of nanoparticles (see section 6.1 for details), to date, no 
standards for the magnetic characterisation of nanoparticles 
have been formulated. One stumbling block is that to develop 
standardised measurements, it is very helpful to be able to 
work with standard reference materials. This, as we have just 
discussed, remains a significant challenge for MNPs. At pre-
sent, no approved reference materials exist for MNP charac-
terisation measurements.
That said, some de facto ‘quasi-standard’ materials are 
being used for specific purposes. One example is the use of the 
commercially available MRI contrast agent Resovist® in the 
development of magnetic particle imaging, a novel method 
for mapping MNP distributions [26]. This is a pragmatic 
approach, which, given the highly-fragmented nature of the 
MNP market sector, is an informative one. Indeed, it has led 
us to the conclusion that rather than attempting to establish 
only a few ‘one-size-fits-all’ standards, a more application-
specific ‘mix-and-match’ approach should be adopted. The 
mix-and-match approach combines different, but comple-
mentary, items from a wider list in order to form a coordi-
nated set which meets the necessary requirements. We discuss 
this below, both from a pedagogical perspective, and in the 
context of recent developments towards a MNP suspension 
standard that is being undertaken through the International 
Organization for Standardization (ISO).
2.2. A ‘mix-and-match’ framework for future  
MNP standardisation
In our opinion, a rational approach to the standardisation of 
products based on magnetic nanoparticles in liquid suspen-
sions is to consider which necessary constituent documents 
should logically be covered in any such standard. In effect, 
the ‘mix-and-match’ approach is to compartmentalise the 
documentation into separate but inter-linked classes. If these 
individual items are suitably well designed, then they can act 
as building blocks to be drawn together and referenced, when 
necessary, as any given body of work develops. Existing ISO 
standards of relevance relating to non-magnetic characterisa-
tion of magnetic nanoparticles (e.g. electron microscopy or 
dynamic light scattering analysis of particle sizes) are already 
in a suitable format to be coupled into the proposed standardi-
sation structure under the ‘measurement standard’ class.
The mix-and-match approach is illustrated in figure 1 as 
a combinatorial map showing the suggested structure around 
which standards relating to MNP suspensions may be built. 
Figure 1. Diagram illustrating the ‘mix-and-match’ framework for the 
standardisation of products based on magnetic nanoparticles in liquid 
suspension. Illustrating the inter-relation between the constituent 
standards classes, viz. definitions; sampling; measurements; labelling; 
and applications. The diagrams illustrate how different standards of 
each class may combine as necessary to provide the coverage required 
for standardisation of a specific MNP application.
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Underlying all of the other document types are the vocabu-
lary standards and materials specifications class, whose con-
tent feeds into the development of each of the other document 
types. The connections between the different classes, and 
the manner in which they build upon the content of others is 
depicted by the arrows. Descriptions of the constituent docu-
ment classes are provided in the following text.
2.2.1. Definitions standards and material specifications. 
These documents fulfil the role of introducing and defining 
terminology specific to a given topic within the standards 
structure. Definitions standards are those whose scope is lim-
ited to the definition of technical terms. Materials specifica-
tions typically contain definitions specific to the material in 
question, as well as additional information such as lists of 
appropriate characterisation measurement techniques, safe 
handling guidelines and labelling requirements.
While some vocabulary pertaining to nanoparticles has 
already been included within published standards, a number 
of key definitions, particularly relating to magnetic character-
istics, have yet to be accepted universally. It is not, for exam-
ple, possible to define a measurement technique to establish 
superparamagnetic behaviour in a MNP sample, until the exact 
meaning of the term is defined in the literature. Harmonisation 
of the terminology used to describe MNPs is therefore the first 
requisite step in the path towards standardisation.
2.2.2. Sampling standards. The need to obtain a representa-
tive usable sample is universal and intrinsic to all techniques 
for the measurement of MNP suspensions. Sampling docu-
ments are reliant on the terminology contained within defini-
tions standards, and are a requisite to feed into documents on 
best practise for conducting characterisation measurements. 
Other aspects of sample preparation and handling may also 
require the compilation of standardised codes of practise. 
Examples of this include the correct pipetting techniques for 
handling nanoparticle dispersions, or the correct methods for 
digestion of samples for measurement of iron concentration.
2.2.3. Measurement standards. As previously described, a 
separate standard should be established for each characterisa-
tion technique. Measurement standards are reliant upon both 
definitions and sampling standards. They are in turn a pre-
requisite in order to formulate more specific standards for 
particular applications. While a number of characterisation 
techniques for nanoparticles have already been the subject of 
ISO standards, at present none exist for characterisation of 
the magnetic properties of MNPs. This is a key area which 
requires development.
2.2.4. Labelling and storage standards. Establishing 
industry consensus on the requirements for MNP labelling 
for use in specific applications can greatly aid end-users of 
the material. Appropriate storage, disposal and health warn-
ings are also of significant importance, particularly given 
the unique and relatively unknown nature of nanomaterials. 
Labelling and storage documents are reliant on the previ-
ous definition of relevant terminology, and are a necessary 
reference in the compilation of a comprehensive application 
standard.
2.2.5. Application standards. This class of document is the 
most advanced in terms of the standardisation infrastructure 
required, as it draws on the content of an established library of 
definitions, measurement and labelling standards. An applica-
tion standard should define the important parameters of rel-
evance for MNPs destined for a particular application, and 
give recommendations for, or define the characterisation tech-
niques suitable to measure them. Information on the appro-
priate labelling of the characterised particles should also be 
included.
The proposed structure is intended to allow the develop-
ment and cross referencing of many interlinked standards with 
the least possible confusion or amendment. Each application 
standard can draw upon the specific documents which are rel-
evant to it. Additional measurement and application standards 
may be developed as and when the need arises.
To give a concrete example (see figure  2), one possible 
application standard that could be envisioned might be on 
the requirements for MNPs for use in magnetic hyperthermia 
therapy. Such an application standard would not stand on its 
own, but instead would be accompanied by both a definitions 
standard (defining the terms associated with single-core and 
multicore MNPs) and a material specification (defining the 
properties characteristic of MNP suspensions, and how they 
may be measured). There would also be a sampling standard 
on how to obtain appropriately representative aliquots from 
an MNP suspension, plus a series of measurement stand-
ards corresponding to each of the parameters needed to fully 
characterise the MNP suspension with respect to its intended 
application purpose: in this case, of magnetic heating [27]. 
The list of measurement standards provided in figure 2—of 
chemical analysis, hydrodynamic diameter, dynamic magn-
etic properties and intrinsic loss power—are examples of the 
sorts of standards that would be required here [28]. (Note this 
is a hypothetical list only: in practise, it will take a good deal 
of work to develop the standards before a definitive list may 
be determined.). Lastly there would be labelling standards (we 
list here two—concentration and stability of the suspension, 
and the magnetic heating capacity of the MNPs themselves—
but there may be others too), and the application standard 
itself, which would bring the entire set together and in which 
the inter-relations between the constituent standards would be 
presented and explained.
In sections 6–10 below, we will examine the current state-
of-the-art in each of the classifications of standard described 
here. We shall then identify the gaps in the existing documen-
tation, and future requirements for MNP standards content.
However, before that, it is important to recognise that 
nanomaterials standardisation work is currently ongoing in a 
number of organisations around the world, and in particular 
that there is a programme under way at ISO that is specifically 
directed towards nanotechnology standards. We review this 
groundwork within the next section. Details of draft standards 
relating to MNP suspensions which are currently under devel-
opment at ISO can be found in section 9 of this review.
J. Phys. D: Appl. Phys. 50 (2017) 383003
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3. Steps currently being undertaken by ISO towards 
MNP suspensions standardisation
This document concentrates primarily upon standardisa-
tion within the framework of the International Organisation 
for standardisation (ISO). This is due to the global reach of 
their documents, and the large body of relevant work already 
underway within the organisation. Recent years have seen 
significant ISO activity towards the standardisation of many 
aspects of nanotechnology. In 2005 an ISO technical commit-
tee (ISO/TC 229) was inaugurated with the specific goal of 
nanotechnology standards development.
Those developing new standards for MNPs should be 
aware of the definitions and terminology already provided 
within the ISO 80004 ‘Nanotechnologies—vocabulary’ series 
of documents. Furthermore, for MNPs being developed for 
use in human healthcare, the content of the ISO technical 
report ‘Nanotechnology—vocabulary in human healthcare’ 
[30] may be relevent. ISO has issued its own guidelines 
regarding the expected content and structure of prospective 
ISO standards [29]. Two key stipulations are given in these 
guidelines: (1) that a separate standard is required for any test 
method which is likely to be referred to in a number of other 
documents; and (2) that if multiple test methods are capable of 
probing a particular characteristic, then each method should 
be the subject of a unique document.
In addition, ISO has published a ‘metrological checklist’ 
to aid assessment of the readiness of particular measurement 
techniques for the development of standards [31]. This check-
list can be used by standardisation organisations, metrology 
institutes, companies, environmental agencies or other stake-
holders intending to propose the development of a new ISO 
standard for measurements on engineered nanomaterials. It 
formulates the basic requirements for developing a quality 
management system for measurements on the nanoscale. The 
content of the metrological checklist is summarised as follows 
(MNP specific comments are below the italics):
 (1) The material subjected to the measurement procedure 
should be clearly described.
  While some terminology is clearly defined, many terms 
relating to the internal structure of MNPs, their magnetic 
properties, and magnetic interactions are not yet covered.
 (2) The definition of the material to be measured should not 
be unnecessarily restrictive.
  Definitions must be consistent across the full spectrum 
of MNP types spanning from small (5 nm) single-core to 
large multicore particles, and the variety of particles in 
between.
 (3) The measurand should be clearly described.
  A measurand is a physical quantity measured by a spe-
cific instrument. In the study of MNPs measurands may 
be probed by remote observations of the system, from 
which we infer MNP properties using models. While 
some physical properties of MNP suspensions can be 
unambiguously defined, e.g. the iron concentration, a 
physically exact definition can be difficult for others, e.g. 
for saturation magnetisation.
 (4) It should be clearly indicated whether the measurand is 
defined operationally (by the methods used), or whether the 
measurand is an intrinsic, structurally defined property.
  To illustrate this point, dynamic magnetic susceptibility 
is an example of an operationally defined property. This 
requires a careful definition of the field amplitude and 
temporal variation in order to interpret the measurand’s 
definition correctly.
Figure 2. Hypothetical example of a set of standards documents that together might constitute the ‘mix-and-match’ set of definitions, 
sampling, measurement and labelling standards to support an application standard covering MNP suspensions for use as magnetic 
hyperthermia agents.
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 (5) The measurement unit should be clearly defined, and the 
metrological traceability of the measurement should be 
pursued.
  Measurements should be defined using SI units. 
Metrological traceability means that the measure-
ment result can be related to an established reference 
measurement through a documented unbroken chain of 
calibrations with defined uncertainties [32]. Metrological 
traceability in the strict sense has not yet been demon-
strated for the magnetic characterisation techniques of 
MNPs.
 (6) The measurement technique should be demonstrated in 
the literature by at least one, but ideally multiple labora-
tories. Results should ideally have been published within 
peer-reviewed journals.
  Many published studies have attempted to provide com-
parisons of the non-magnetic properties of particles [33, 
34]. For example, thorough interlaboratory comparison 
of nanoparticle size analysis has already been reported 
[39]. Comparative studies of magnetic properties 
measurements are sparsely reported at present [35–38]. 
Additional studies to provide further coverage is a key 
task for the future, these could eventually be performed 
within the organisational framework of VAMAS [40] or 
using the model offered by other published interlaboratory 
compariso ns [41].
 (7) Quality control tools should be developed in order to 
validate the proficiency of a laboratory in performing the 
technique.
  Proficiency testing involves the use of interlaboratory 
comparisons for the determination of laboratory perfor-
mance, the tests are performed by accredited providers 
[42]. Results of proficiency tests can be useful for 
customers, regulators, laboratory accreditation bodies 
and other organizations that specify requirements for 
laboratories [43]. Currently, there exists no compre-
hensive methodology to perform proficiency tests for 
characterization of MNPs. Achieving this would require 
the development of suitable protocols for sample treat-
ment and measurements, standardized representation of 
results and data analysis, and the availability of stable 
MNP reference materials which could be used in such 
tests.
 (8) The instrumentation required in order to perform the 
measurement should be widely available.
  The availability of instruments varies significantly 
depending upon the measurement technique in question.
 (9) An uncertainty budget for the measurement should be 
developed, or at least a list of the measurement uncer-
tainty components must be provided.
  The measurement uncertainty is a non-negative param-
eter that expresses the level of doubt about the validity 
of a result given by a measurement [43]. An uncertainty 
budget is a quantitative statement of the measurement 
uncertainty, of the constituent components of that 
measurement uncertainty, and of their calculation and 
combination. For the magnetic properties of MNP, full 
uncertainty budgets have been presented in a few iso-
lated cases including Mössbauer spectrometry [44] and 
magnetic hyperthermia [45]. Generally, it is a task for the 
future to describe the magnetic properties measurements 
of MNPs according to the internationally accepted ‘Guide 
to the expression of uncertainty in measurement’ [46].
 (10) Characterisation methods must be properly validated 
in at least one laboratory. This means that the working 
range, sensitivity, repeatability and other factors must be 
known.
  The level of advancement varies dramatically between 
different techniques. In general, a significant amount 
of work is still required in order to achieve this for the 
majority of measurements.
From this, it is clear that the ‘mix-and-match’ methodology 
proposed in section 2 is well aligned to meet the requirements 
placed by the ISO drafting guidelines, and that careful atten-
tion needs to be given not only to the measurements standards, 
but also how they relate and feed into each of the other classes 
of standards. We therefore now proceed to review the current 
status and future requirements for the five classes of docu-
ments introduced in the mix-and-match structure for MNP 
standards.
4. Standards for MNP definitions and technical 
specifications
It is impossible to form a coherent standardisation structure 
for MNP suspensions without first defining the terminology, 
concepts and properties which must be considered. In this 
section, we examine the current coverage of ISO standards 
in the field and introduce some of the key concepts which 
must be defined in order to standardise both MNPs and their 
suspensions.
4.1. Coverage of published standards
Two published ISO documents deal specifically with vocabu-
lary relevant to nanoparticles, although they do not consider 
the particular case of nanoparticles formed from magnetic 
materials:
In the technical specification document ISO 17200:2015, a 
number of characteristics relating to dry powders of nanopar-
ticles are defined [47]. While some of this document’s content 
is of relevance for MNP suspensions, in general the scope is 
not sufficient for those working with either magnetic particles, 
or for nanoparticles in suspension.
In the ISO 26824:2013 document, a dictionary of agreed 
definitions with relevance to the characterisation of nanoparti-
cles is set out [48]. While not being comprehensive, its content 
includes material relevant to the characterisation of particles 
in both dry powders and in liquid dispersions. Vocabulary of 
relevance to dynamic light scattering, small angle x-ray scat-
tering, and zeta potential measurements is also presented.
Hence, although some terminology of relevance to MNPs 
and MNP suspensions is defined within existing documents, 
there is currently a lack of cohesion, consistency and coverage. 
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Moreover, the existing standard definitions primarily describe 
the outer contours and surfaces of materials at the nanoscale. 
There is a lack of definitions, firstly of the MNP itself, and 
secondly of an ensemble of particles in a suspension medium. 
With regards to the former, there is almost no discussion at 
present of either the internal structures and/or the composi-
tions of nanoscale particles or other nanomaterials, both of 
which are critical in the study of MNPs as it is the physical 
arrangement that dictates the magnetic properties of the par-
ticle. Taking this a step further, nanoparticle suspensions con-
sist of both the particles and the liquid within which they are 
dispersed and have properties and considerations which are 
not applicable in the case of dry powders. There is currently 
a lack of definitions or descriptions of nanoparticle suspen-
sions within the literature. Such properties and definitions are 
not unique to magnetic NPs, and thus belong within a specific 
document on the appropriate terminology and concepts for 
generic nanoparticle dispersions.
Somewhat remarkably, at present there is no description 
or definition of the magnetic properties of MNPs within pub-
lished standards. The term ‘superparamagnetic’ is mentioned 
within [49], however no description of the meaning is offered 
beyond it being an effect observed within ‘small particles 
formed of metal oxide’. This is an effect which is well estab-
lished within the scientific literature [50], and which underpins 
many applications of MNPs. It will be impossible to develop 
measurement standards in order to characterise MNPs until 
their unique magnetic properties have been defined.
In the following subsections, we introduce key concepts in 
the classification and description of magnetic nanoparticles, 
which we believe are of vital importance specifically for the 
characterisation and description of MNPs.
4.2. Standardisation requirements
In the following sections, the major characteristics and prop-
erties of MNPs which must be considered for accurate char-
acterisation are outlined. These are the topics which should 
eventually be covered within definitions standards in order to 
offer coverage suitable for all application possibilities.
4.2.1. Structure of magnetic nanoparticles. A vast variety of 
particle structures have been reported in the literature. How-
ever, all of the known variants have included some, or all, of 
the following components. As such, we consider that in order 
to aid the harmonisation between MNP manufacturers and 
users, the following concepts should be incorporated into the 
standardisation literature.
4.2.1.1. Magnetic cores. The fundamental building blocks 
of magnetic nanoparticles are called cores [11]. They are 
individual nanoscale magnetic objects formed of a magnetic 
material. Each core may be a single crystallite of magnetic 
material (meaning that the crystalline lattice is coherent and 
unbroken throughout the object), or have a polycrystalline 
structure (meaning that the crystalline lattice within the object 
has two or more distinguishable orientations).
The simplest MNP is that which contains just one magnetic 
core – a ‘single-core’ magnetic nanoparticle. Figure 3 shows 
a schematic diagram of a single-core MNP, along with other 
constituent components (matrix, functional shell, hydrody-
namic surface layer) that we discuss further below.
The size and composition of each magnetic core, as well as 
their spatial distribution relative to other cores (see later with 
respect to ‘multicore’ MNPs), affects the magnetic properties 
of the overall particle system. When reduced below a critical 
size, it becomes energetically unfavourable for domain walls 
to form within a magnetic core. As a result, cores smaller 
than this limit will form single domains, with all of the spins 
aligned in a common direction.
Magnetic cores can be formed from a range of metals and 
metal oxides, often with the choice of material dictated by 
the choice of application. For example, while pure magnetic 
 metals offer high magnetisation (magnetic moment per unit 
volume) values, they are generally not suitable for biomedical 
or environmental applications due their toxicity and sensitivity 
to oxidation. In general, particles formed from metal oxides 
exhibit a greater long term stability, although pure metal may 
be rendered stable if protected from oxidation by sufficient 
layers of oxide or other materials such as gold or carbon.
Magnetic iron oxides, such as magnetite (Fe3O4) and magh-
emite (γ-Fe2O3) are among the most commonly-used mat-
erials in MNP systems for biomedical application, due to their 
non-toxicity and stability from oxidation [51]. To date iron 
oxide particles are the only MNP products so far approved for 
administration to humans [52], these being: the MRI  contrast 
agent Resovist®, the iron replacement agent Feraheme®, the 
sentinel node detection agent Sienna+®, and the magnetic 
thermoablation agent NanoTherm™.
Figure 3. Schematic diagram of a single-core magnetic 
nanoparticle. Note that the magnetic core is a single magnetic 
object that may be either a monocrystalline or polycrystalline single 
magnetic domain, which responds to an applied magnetic field in a 
single, net, coherent manner.
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Other magnetic metals and oxides (including iron, nickel, 
cobalt and more complex oxides) have all been studied, with 
many exhibiting unique and useful properties. One of the key 
challenges to the introduction of products implementing these 
particles, however, is the need to conduct thorough studies of 
the environmental and health impact which such nanomat-
erials may incur. This is an ongoing topic in the development 
of MNP standardisation [53].
4.2.1.2. Non-magnetic matrix. If dispersed in a liquid, 
uncoated magnetic cores tend to aggregate over time due to 
the influence of Van der Waals forces and magnetic dipolar 
interactions. This tendency towards aggregation is detrimental 
to many applications, where stability of the particle dispersion 
over time is often a key requirement. To reduce the risk of 
aggregation or sedimentation, a non-magnetic encapsulating 
matrix (sometimes referred to as a coating) may be added to 
the cores, either as an integral part of the original synthesis 
route to the material, or a part of a post-production treatment 
phase. Such matrices/coatings stabilise the colloid by provid-
ing steric and/or electrostatic repulsion between the particles 
to prevent aggregation [54, 55].
In addition to stabilising the MNP suspension, matrix 
coatings may serve a variety of other functions, including 
aiding the particles’ biocompatibility [54, 56], or providing 
an anchor layer to which functional groups may be attached 
[57, 58]. The material used for the coating is dictated by the 
application for which the particles are destined, with organic 
materials such as sugars or starches being commonly used for 
coatings, particularly in biomedicine.
It should be noted that it is not always necessary for the 
cores to be covered with a non-magnetic matrix, but it is 
also true that a large majority of the MNPs currently being 
produced, studied and used around the world do have such a 
matrix coating. It should also be noted that in almost all cases 
the matrix is produced as part of the synthesis stage rather 
than afterwards. The matrix material is often a relatively dense 
polymeric or organic material that is insoluble in the intended 
suspension fluid for any given system, so that it is the matrix, 
rather than the magnetic core, that has a surface interfacing 
with the suspension medium. Furthermore, the matrix is often 
relatively rigid, and is either intrinsically electron-dense (in 
the case of silica), or can be made to be electron-dense by 
staining with heavy metal ions. By doing this the particles 
exhibit measurable Z-contrast, and are therefore both visible 
and distinct in transmission electron microscopy.
Given these features, it is not surprising that the term ‘parti-
cle’ has come to be applied to the composite core-plus-matrix 
system. In other words, the ‘particle’ in ‘magnetic nanopar-
ticles’ usually refers to a system comprising a magnetic core 
encapsulated within a non-magnetic matrix. In systems where 
there is no matrix—commonly referred to as ‘naked’ or ‘bare’ 
nanoparticles, the ‘particle’ in question is the magnetic core 
on its own.
4.2.1.3. Functionalised shell and hydrodynamic layer. Both 
biomedical applications and environmental remediation tech-
niques commonly require that functional ligands be attached 
to the surface of the MNPs. By comparison with the core(s) 
and matrix of a particle, the ligands have relatively low den-
sity and different composition, however, this can be difficult 
to detect directly. They are closely associated with the surface 
of the particle, and are bound to that surface either through 
covalent or ionic force that they can withstand the shearing 
stresses associated with the boundary interface between the 
particle and the suspension medium.
The incorporation of a functionalised shell is an important 
aspect of many applications of MNPs in liquid suspensions. 
These include: to enable binding to biomolecular targets for 
immunoassays; to enhance the accumulation of particles 
within a specific biological organ or tumour; to act as a vector 
to transport drugs around the body; and to facilitate the isola-
tion of pollutants from water.
Lastly, a hydrodynamic layer—or, more generally, a 
boundary layer—exists at the interface between the particle 
(and its functionalised shell, if present) and the suspension 
medium. (Strictly speaking, the term ‘hydrodynamic layer’ 
applies only when the suspension medium is water-based.) 
The boundary layer forms as a natural consequence of the 
very different viscosities of the particle and the suspension 
medium, in that the fluid right next to the particle sticks to 
the particle, and acts to shear or ‘slow down’ the fluid next 
to it. The boundary layer thickness is then defined by the 
distance from the particle surface at which the influence of 
the particle on the dispersing medium is no longer appar-
ent. In water-based suspensions, the hydrodynamic layer is 
typically of the order of 5–10 nm thick. When the MNPs are 
immersed in biological liquids like blood or serum they are 
 intrinsically surrounded by an additional layer of proteins, 
the so-called corona, further increasing the effective hydro-
dynamic  diameter [59].
4.2.1.4. Multicore particles. Multicore magnetic nanopar-
ticles—as illustrated in figure  4—are particles that contain 
more than one distinguishable magnetic core, where ‘dis-
tinguishable’ means that the cores are embedded within a 
non-magnetic matrix, and that there is a physical separation 
between neighbouring cores that is filled with the matrix 
material. If the cores of a muticore particle are sufficiently 
tightly bunched, then the term ‘nanoflower’ is used to describe 
them. This class of particles has been demonstrated to show 
great promise for a variety of applications including magn-
etic hyperthermia therapy [45, 60] and magnetic resonance 
imaging [61]. Note that if there were no physical separation 
between adjacent cores, then the assembly would behave as a 
polycrystalline single-core particle.
In defining the structure of multicore MNPs, it is conveni-
ent to use the term ‘core-cluster’ to describe the dispersion 
of the cores within the matrix (see figure  4). This leads to 
other parametric descriptions that may be applied to multicore 
MNPs, including the number of cores per particle; the core-
cluster diameter; and the density of the core-cluster. Changes 
in these parameters reflect significant changes in the packing 
arrangement, meaning that the spacing of the cores within the 
particle is variable, and can greatly affect its characteristics—
as illustrated in figure 5.
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Multicore MNPs are often a natural product of one-pot 
synthesis routes in which the magnetic cores and the non-
magnetic matrix material coexist at the time of formation. 
The presence of numerous cores may also be advantageous 
in functional terms, such as by increasing the overall magn-
etic content of given size particle, while still allowing the 
formation of stable colloids. Furthermore, magnetic dipole-
dipole interactions between the cores in multicore particles 
have been implicated as being beneficial for applications 
including magnetic hyperthermia [62] and magnetic particle 
imaging [63].
4.2.2. Particle size. Due to their internal structure, and the 
additional complexity of particles distributed in liquid suspen-
sions, a number of important size quantities are necessary in 
order to properly describe MNPs.
4.2.2.1. Core, core-cluster, particle, functionalised shell and 
hydrodynamic sizes. The core size describes the sizes of the 
individual magnetic cores, whether the particles are single-
core or multicore entities. In multicore MNPs the core-cluster 
size refers to the size of the region of the non-magnetic matrix 
within which the cores occur. The particle size describes the 
size of the entire particle, i.e. the combination of the magnetic 
core or cores plus the non-magnetic matrix that those cores 
are embedded within. All of these are sizes that are in prin-
ciple measurable in both the liquid suspension state and in the 
dried state.
For particles in suspension, however, two further sizes 
are significant. The functionalised shell size refers to the 
size of the physical particle as well as that of the (frequently 
biomolecular) functionalised surface layer. The hydrody-
namic size includes the boundary layer between the particle 
(and its functionalised shell if present) and the suspension 
medium.
4.2.2.2. Size distributions. All size quantities relating to any 
particulate or nanoparticulate matter have an associated size 
distribution, that is to say there is a mean value and a range 
which is quantified by a distribution width. The distribution of 
particle sizes can vary greatly and has a strong impact on their 
characteristics and potential uses. The polydispersity index of 
a particle ensemble is given by the standard deviation of the 
particle sizes divided by the mean of their sizes. If this value 
is smaller than 0.25, then the particles are described as being 
monodisperse or uniform. When the distribution is larger than 
this, the particles are described as being polydisperse [64, 65]. 
Standard techniques for characterising particles as mono- or 
polydisperse are given in the following ISO standards [66, 
67]. Particle sizes are typically described by a log-normal dis-
tribution, or more complex multi-parameter models may be 
required [68, 69]. As with all MNP characterisation, appropri-
ate sampling must be achieved in order to give a representative 
value for the full population of particles.
When contemplating particle/core size distributions, a 
common issue which must be considered is whether the meas-
urement output is a distribution in terms of volume, number or 
intensity. Additional information on this subject can be found 
in [70].
4.2.3. Zeta-potential and stability of suspensions. The zeta 
(ζ) potential is a measure of the potential difference between 
the dispersion medium and the stationary layer of fluid 
attached to the dispersed particle. The ζ-potential provides a 
key indicator of the stability of colloidal dispersions, which is 
critical to many applications.
It follows, then, that this value is an important metric for 
any nanoparticle solution, but particularly so for MNPs as 
small attractive forces between magnetic cores may exceed 
the repulsion, resulting in aggregation of the dispersion. In 
general, the larger the value of the ζ-potential, the greater 
the stability of the suspensions against aggregation. Further 
stability can be conferred to the particle dispersion by the 
addition of charged functionalised ligands to the particle sur-
face through a process known as ‘electrostatic stabilisation’. 
Finally, the choice of solvent used in the particle suspension 
will also greatly influence the ζ-potential value obtained as 
variation in the pH value can greatly affect the stability of the 
suspension.
Alternatively, MNPs may be stabilised sterically by the 
addition of a coating layer of large polymer molecules such as 
polysaccharides. Electrostatic and steric stabilisation methods 
may be combined to form electro-steric stabilisation. Steric 
stabilisation methods are less susceptible to changes in the in 
the ionic strength or pH, and thus steric or electro-steric stabi-
lisation is preferable for some applications [71].
4.2.4. Chemical composition. The chemical composition 
of nanoparticle products is of utmost importance, especially 
when validating them for use in medical, biological, or 
environ mental technologies. Analysis of the chemical com-
position can also indicate the extent of impurities which are 
present within particles. For iron oxide MNPs, Mössbauer 
spectr oscopy or x-ray diffraction can further aid in discerning 
Figure 4. Schematic diagram of a multicore magnetic nanoparticle.
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which ferrite phases are present. Thus far magnetite (Fe3O4) 
and maghemite (γ-Fe2O3) are the only ferrites which have been 
approved for use in humans [72]. To characterise MNPs for 
some applications, a complete understanding of the particle 
composition including the crystal structure, extent of defects 
and the presence/extent of impurities may be necessary [73].
Magnetism in nanoparticle suspensions
In this section  we introduce key magnetic concepts which 
are necessary considerations when characterising magnetic 
nanoparticles in liquid suspensions.
4.2.4.1. Superparamagnetism. Superparamagnetism occurs 
when a single domain magnetic core is sufficiently small such 
that the thermal energy is sufficient to overcome the energy 
barrier to magnetisation reversal [50]. This allows the magn-
etic moment of the core to flip between orientations in the easy 
axes, within the timescale of the used measurement technique 
(measurement time). The temperature above which a particle 
exhibits superparamagnetic behaviour is the blocking temper-
ature (TB). Below this, the thermal energy is insufficient to flip 
the magnetic moment within the measurement time [74], and 
the particle is described as being thermally blocked. For iron 
oxide MNPs, typically core sizes less than 20 nm are super-
paramagnetic at room temperature (when measured using 
common DC magnetometry apparatus with measurement 
times of several seconds).
Above the blocking temperature, thermally activated switch-
ing occurs frequently (see following section on relaxation mech-
anisms), as a result the average magnetisation of a large ensemble 
of cores is zero in zero field. An ensemble of superparamagnetic 
particles exhibits no remanent magnetization in zero applied 
field and no magnetic coercivity although a magnet isation may 
be temporarily induced within the ensemble by the application 
of a magnetic field. If the magnetic field is removed, the ensem-
ble magnetisation quickly decays due to thermal agitation of the 
particle orientations. The ability to induce a large magnetisation 
in superparamagnetic particles, without causing aggregation of 
the MNP suspension (as tends to happen in thermally blocked 
particles), is of great interest in a large number of applications 
including sensing and focussing [75, 76].
It should be noted that the observation of superparamag-
netism is closely linked to the timescale of the measurement 
Figure 5. Illustration of factors affecting the properties of the core-cluster within a multicore magnetic nanoparticle. The term nanoflower 
may be applied for the most densely packed core-assemblies.
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technique used. A particle may appear to be superparamagn-
etic when probed using one measurement technique, and yet 
appear to exhibit a remanent magnetisation when measured 
using a method with a shorter measurement time.
In liquid suspensions of MNPs, superparamagnetic proper-
ties may still be observed within thermally blocked particles if 
they are suitably free to rotate within the suspension liquid and 
the thermal agitation of the system is sufficient to result in ran-
dom reorientation of the particle via Brownian reorientation.
4.2.4.2. Relaxation mechanisms. The orientation of MNPs in 
suspension can relax via two distinct mechanisms: Néel relax-
ation or Brownian relaxation. In Néel relaxation, the magnetic 
moment flips direction within the particle due to thermal agi-
tation, with an average time between these reversal given by 
(τN) [77]. For a temperature T, a system of non-interacting 
(in zero field) single-core particles has a characteristic Néel 
relaxation time τN given by:
τN = τ0 exp
[
KVc
kBT
]
,
where τ0 is a material dependent time constant (typically in 
the range of 10–12–10–9 s), KVc is the total anisotropy energy 
of the particle core, and kB is the Boltzmann constant. The 
Néel relaxation behaviour of a given type of particle is dic-
tated by the size, shape and distribution of the cores (which 
may be interacting if the packing density in the core-cluster is 
high) within the matrix.
For liquid suspensions of MNPs, reorientation of a parti-
cle’s magnetic moment may also be caused by a physical rota-
tion of the whole particle within the suspension medium and 
unless they have been specifically immobilised, this provides 
an additional degree of freedom to the magnetisation align-
ment of nanoparticles. Magnetisation realignment through 
physical rotation of the particle is known as Brownian relaxa-
tion, which occurs with characteristic time τB which is given 
by:
τB =
3VHη
kBT
,
where VH is the hydrodynamic volume of the particle, and η is 
the viscosity of the carrier liquid.
A liquid suspension of nanoparticles may be dominated by 
either Néel or Brownian relaxation depending upon a combi-
nation of factors including the particle size, structure (single 
or multicore), the liquid in which they are dispersed and the 
temperature of the system.
In a multicore particle, individual cores are unable to 
physically rotate due to the matrix in which they are anchored 
and whilst this prevents Brownian relaxation of the individ-
ual cores from occurring, the overall particle, however, may 
still rotate within the suspension. In this case, the relaxation 
behaviour of the particle is determined by a combination of 
Néel relaxation within the individual cores and the Brownian 
relaxation of the overall particle. As a result, a multicore par-
ticle may appear to exhibit either Néel or Brownian relaxation 
in the same manner as a single-core particle.
For both single- and multicore particles. The effective 
relaxation time, τeff ,of the MNP suspension accounting for 
both Néel and Brownian contributions can be deduced using:
τeff =
τNτB
τN + τ B
.
Further discussion of the contributions from both Néel and 
Brownian relaxation processes is described in [78].
Relaxation behaviours are important in a variety of MNP 
applications, particularly in biomedicine. These include magn-
etic biosensor detection systems [79–82], inducing localized 
magnetic hyperthermia treatment to kill tumour cells [83], as 
well as providing or enhancing contrast in magnetic particle 
imaging [84] and magnetic resonance imaging [85]. The type 
of relaxation exhibited by a MNP suspension therefore has 
great implications for its applicable uses, and so this is a criti-
cal characterisation parameter.
4.2.4.3. Interactions between particles. Interactions between 
MNPs within a system can have a strong influence the group 
behaviour [86], and thus are an important consideration dur-
ing magnetic characterisation. The magnetic moment of indi-
vidual MNPs can easily exceed 10 000 μB (Bohr magneton), 
and the resultant dipole interactions act over long distances to 
influence the magnetic properties of the system. For a set of 
randomly distributed particles with average magnetic moment 
μ and average separation d, an estimate of the dipole interac-
tion energy of a particle using:
Ed ≈ µ04pi
µ2
d3
,
where μ0 is the permeability of free space.
If the concentration of a suspension of superparamagnetic 
MNPs is sufficiently high then the magnetic dipole interaction 
can result in ordering of the particles at temperatures below a 
critical value T0 [87], as given by:
T0 ≈ EdkB .
Dipolar interactions can significantly affect the results 
obtained from static and dynamic magnetization as well as 
other characterization measurements. They are also a rel-
evant factor when synthesising MNPs for optimal magnetic 
hyperthermia performance [88–91]. If particles are packed 
very closely within a core-cluster, then exchange interactions 
between the cores may start to influence the overall behaviour 
of the particle.
5. MNP sampling standards
Obtaining accurate representative samples for analysis from 
bulk synthesis products is a critical requirement for all charac-
terisation measurements, as well as for quality control in pro-
duction. The sampling is typically based on volumetric (e.g. 
pipetting) and/or gravimetric (weighing) methods. Minimal 
uncertainty in sample volume or weight can be achieved 
by choosing a standardised calibration and measurement 
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technique. For MNP suspensions, volumetric sampling is 
more straightforward, and traditionally used by the industry. 
However in most cases it is less accurate than weighing. For 
example, the accuracy of the volume obtained by pipetting 
depends on physical factors such as liquid density, viscosity, 
vapour pressure and evaporation, surface tension, air pressure, 
temperature of the ambient and the liquid, as well as on cali-
bration accuracy, pipetting technique and operator skills. The 
uncertainty of the calibrated laboratory micropipettes is in the 
order of 10−2–10−1 μl [92].
The gravimetric method such as weighing by laboratory 
balance is more precise and in fact is typically used to cali-
brate the pipettes or laboratory glassware. Still, the meas-
urement is sensitive to the characteristics of the balance, 
such as readability, repeatability, nonlinearity, sensitivity 
accuracy and temperature coefficient, to the influences that 
caused by environment such as air humidity, temperature, 
pressure and influences that affect the weighing object such 
as air buoyancy, way of loading the sample, etc. The uncer-
tainty of the calibrated laboratory balance is in the range of 
10−4–10−3 mg [93].
As a general rule, prior to sampling, the MNP suspension 
needs to be homogenized (e.g. shacked, vortexed, sonicated) 
to diminish effects of segregation or sedimentation during the 
storage, and if bulk volume is large, the sampling needs to be 
done from different locations of the container. Sampling size 
and number has to be correctly selected based on the follow-
ing analysis method and sample properties.
When sampling MNP suspensions, precautions should be 
taken to avoid unintentional exposure to the external magnetic 
fields or magnetic materials in sampling devices as they can 
affect composition and properties of the sample.
Accurate and appropriate sampling is a key requirement 
when compiling an uncertainty budget for a specific measure-
ment. Uncertainty budgets are specified within the metrologi-
cal checklist (summarised in section 3) as being a necessary 
precursor to the development of ISO standards for measure-
ment techniques.
5.1. Coverage of published standards
Here, we briefly discuss the existing standards covering the 
topic of obtaining MNP samples in liquid or powder forms.
Acceptable methods for obtaining particulate samples 
which are representative of the size, size distribution and sur-
face areas are described in ISO 14488:2007 [94]. This ISO 
document deals mainly with sampling from dry powders of 
particles. It briefly covers the sampling of particles in pastes 
and suspensions. Many of the recommendations which it con-
tains are not suitable for sampling MNPs in liquid suspen-
sions. For example, the standard recommends the ‘rinsing 
residual particles from equipment to ensure the inclusion of 
all particulate matter in the sample’, which is not appropriate 
for the study of particle suspensions as it would alter their 
concentration, which could in turn affect their stability.
Best-practise guidelines for the sampling of particles are 
also found in British standard BS 3406-1 [95], although it is 
worth noting that this document does not specifically pertain 
to nanoparticles. Rather, the document primarily deals with 
particles of much larger dimensions than the nanoscale and 
whilst there are some sections which discuss the sampling of 
liquid suspensions and of obtaining samples of particles with 
sizes of less than 20 μm, this is still 3 orders of magnitude 
larger than typical particle sizes in MNP suspensions
Techniques for sampling from large volumes of colloidal 
suspensions such as paints and varnishes are specified in ISO 
15528:2013 [96]. While the document deals with the sam-
pling from liquid suspensions, its applicability to the specifics 
of MNP analysis requires further examination. Indeed, addi-
tional information with relevance to the sampling of nanopar-
ticles may be found within ISO/TS 12025 [97], which deals 
with the quantification of nano-objects released by the gen-
eration of aerosols. Even though the techniques listed within 
the existing documents listed above may provide appropri-
ate samples for some measurement techniques, their validity, 
however, remains to be established.
Besides the need for standard techniques for acquiring 
representative samples from bulk material, additional sample 
processing is sometimes required in order to optimise some 
measurement techniques. For example, samples containing 
very polydisperse MNP suspensions may require fractiona-
tion of a suspension so as to sort the sample particles into size 
categories before characterisation with DLS [98].
5.2. Standardisation requirements
Precise sample preparation is of the utmost importance in the 
analysis of MNP suspensions. As it stands, there are currently 
no documents within the published literature that specifically 
address the topic of sampling nanoparticles in suspension. 
Instead, existing standards have largely been written without 
consideration of the specific requirements of MNP characteri-
sation methods. It is our recommendation that an evaluation 
of existing standards should be undertaken, with the sampling 
requirements of each MNP characterisation technique indi-
vidually surveyed, as each technique is subject to its own set 
of unique prerequisites.
Specific considerations that should be made when sam-
pling from liquid suspensions of MNPs regard the residual 
environmental magnetic field in the preparation space and the 
magnetisation of any tools or material used in handling the 
liquid.
6. MNP measurement standards
A rigorous characterisation of MNPs in liquid suspension 
requires a large number of chemical, structural, and magnetic 
properties to be considered. However, as it is often the par-
ticular usage that determines the necessary parameters for 
characterisation (illustrated in figures 1 and 2), our ‘mix-and-
match’ approach can simplify the task of amalgamating the 
necessary information for characterising MNPs for a specific 
application. Here, we turn our attention to the existing stan-
dards that are specific to the characterisation of MNPs and 
MNP suspensions. We then examine a selection of the most 
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commonly used techniques that are currently used to charac-
terise MNPs and MNP suspensions which, due to their level of 
applicability, we believe deserve to be standardised.
6.1. Coverage of published standards
There are a number of national and international standards 
which provide best practice guidelines that should be fol-
lowed when characterising nanoparticle samples. The level of 
detail included varies from document to document, with all of 
them being subject to continuous review and improvement. 
Of the existing nanoparticle particle standards, the following 
are applicable to the characterisation of MNPs and MNP sus-
pensions: electron microscopy (ISO 13322-1, [99]) and x-ray 
diffraction (BS-EN 13925-1:2003, [100]), both of which are 
limited to dry material only; small angle x-ray scattering (ISO 
17867:2015, [101], which, by virtue of analogous principles, 
can also be applied to small angle neutron scattering; photon 
correlation spectroscopy (ISO 13321:1996, [66]); dynamic 
light scattering (ISO 22412:2008, [67]) and determination of 
the zeta potential (ISO 13099, [102])—all of which use dilute 
MNP suspensions. Finally, the analysis of particulate material 
within water using inductively coupled plasma mass spectr-
oscopy is covered in [103–106] (the individual documents all 
work together to form the full body of information necessary 
for ICP measurements). In addition there are a number of non-
technique-specific documents relating to analysis methods for 
particle size and colloidal stability [107, 108].
6.2. Standardisation requirements for magnetic  
measurements on MNPs
Somewhat remarkably, at present there are no standards at 
either national or international level for any characterisation 
methods of the magnetic properties of MNPs or MNP sus-
pensions. Accurate and precise determination of the magnetic 
properties is necessary in order to assess not only the func-
tionality, but also the stability and safety of MNP suspensions. 
With this in mind, the development of a standardised descrip-
tion would not only benefit research science, by facilitating 
interlaboratory comparison of results, but also clinical and 
technical applications of MNPs. Here, we describe the most 
common measurement techniques that are currently used to 
characterise the magnetic properties of MNPs. We discuss 
the state-of-the-art of magnetic characterization and outline 
obstacles in the interpretation of measurement results that 
must be overcome for standardization. It is not our intention 
to provide solutions for each issue, this section  rather pro-
vides suggestions of important work areas and issues to be 
addressed in the future.
6.2.1. DC magnetometry. DC magnetometry describes a 
variety of measurements in which the magnetic moment of an 
MNP sample (either as an MNP suspension, an immobilised 
sample or as a powder) is measured as a function of either an 
applied static magnetic field H, temperature T or measurement 
time t. DC magnetometry represents one of the most com-
mon measurement techniques reported within the literature, 
and yet there no standardised methodologies suitable for the 
application of the technique to MNP characterisation. The 
unique properties of MNPs mean that the existing document 
standards, which relate to macroscopic magnetometry, are not 
transferable to this particular class of measurements [109] and 
so necessitates a need to develop additional standards that 
reflect the unique properties and requirements of MNPs.
Through this technique, one can measure the total magnetic 
moment of an MNP ensemble in saturation and, assuming 
the volume of the magnetic material is known, the saturation 
magnetization MS can be deduced. In case of immobilised 
and/or thermally blocked MNPs, the magnetic remanence and 
the coercive field can also be measured. The models used to 
analyse the measurements vary in complexity and number of 
system parameters. In the case of an ensemble of non-inter-
acting identical particles at T  TB (i.e. superparamagnetic 
particles) neglecting magnetic anisotropy effects, the ensem-
ble magnetisation can be described by the Langevin function:
M (H, T) = Ms
(
coth
(
µpµ0H
kBT
)
− kBT
µpµ0H
)
,
where μpμ0H is the magnetic Zeeman energy and kBT the ther-
mal energy of an MNP with the magnetic moment μp.
In the case of T  TB (i.e. thermally blocked particles), 
magnetic anisotropy negates the use of the Langevin expres-
sion and instead there are a number of models in the literature 
that may be applied to describe the particles’ behaviour, as dis-
cussed in [110–112]. Dipolar interactions can occur in MNP 
systems with complex core-cluster arrangements, in which 
case the modelling complexity often needs to be increased. 
In this case, Monte Carlo simulations have been demonstrated 
as a feasible method to model such systems [113, 114], or a 
numerical inversion process may be implemented [38]. The 
thermal response of the MNP sample can also be determined 
from DC magnetometry measurements. Such measurements 
may be conducted either in large (saturating or near saturating 
fields) (S/NS), or under small fields (zero field cooled/field 
cooled loops, ZFC/FC magnetisation). In S/NS measurements, 
the sample is initially cooled to cryogenic temperatures under 
a large applied field after which the sample magnetisation is 
recorded over the desired temperature range. The temperature 
dependence of the saturation magnetisation is typically fitted 
using Bloch-type law:
MS (T) = MS(0) (1− BTα) ,
where B is the Bloch constant. In bulk materials, α has a value 
of 3/2, although deviations from this value have been reported 
for nanoparticulate samples [113] with suggested mechanisms 
including the low-temperature freezing of surface spins [115] 
and or the quantum confinement of spin-waves [116].
ZFC/FC magnetisation measurements are more com-
monly found in the literature and tend to form typical part of 
the characterisation of almost all MNP samples. To measure 
ZFC magnetisation curves, one begins by initially cooling a 
demagnetised sample in the absence of a magnetic field. Once 
the minimum desired temperature is reached (T  <  TB, prefer-
ably  <  10 K), a small magnetic field (ca. 1–20 mT) is applied 
and the sample magnetisation is recorded as a function of 
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
14
increasing temperature until T  >  TB (typically room temper-
ature). Following this, the FC magnetisation curve—the cool-
ing curve is then recorded as the temperature is decreased to 
T  <  TB, under the same applied field. From such measure-
ments it is possible to determine the blocking temperature 
and, provided that the core is size is well characterised, the 
magnetic anisotropy constant can be estimated [117].
The presence of dipolar interactions within an MNP sam-
ple—either within the core-cluster or between particles, will 
shift the blocking temperature peaks in the ZFC/FC magnet-
isation curve [86]. These are highly sensitive to sample prep-
aration and may be minimised by using sufficiently dilute 
MNP suspensions, although such effects may still occur in 
systems where core-clusters are interacting amongst them-
selves. Further complications may also arise when studying 
very small particles (<10 nm). This is because for such ultr-
asmall particles, their anisotropy energy is comparable to the 
thermal energy of the system.
6.2.2. Dynamic magnetic analysis. AC susceptibility (ACS) 
measurements probe the magnetisation of a sample under 
the application of a sinusoidal AC magnetic field. The field 
amplitude is selected to be small enough to probe only the 
linear dynamic magnetisation response of the MNP ensemble. 
The dynamic magnetic response is recorded as a function of 
the excitation frequency. It is described by two components, 
one that is in-phase with the excitation field (real part), and 
one which is out-of-phase (90 degree phase shift, the imagi-
nary part). In relation to the applied field, the recorded signal 
is interpreted as a complex magnetic susceptibility (with the 
above mentioned real and imaginary parts). The frequencies 
typically employed are in the range of 1 Hz–10 MHz. The 
response of the sample at varying temperatures may also be 
measured.
From ACS spectra a number of parameters can be extracted, 
these include the median hydrodynamic size distribution of 
particles [118], the core size distribution (if additional param-
eters are known), whether Néel or Brownian relaxation domi-
nates and the characteristic relaxation times of the system 
[78]. In some cases, an estimate of the specific absorption rate 
of particles (see section 6.2.3) may be made from the imagi-
nary part of the AC susceptibility [122].
Temperature dependent AC susceptibility measurements 
(ACS versus temperature at different excitation frequencies) 
can provide information about the core volume distribution 
and allow the magnetic anisotropy constant to be obtained 
if the MNP system is non-interacting. Analysis is somewhat 
complicated if there is a distribution of particle shapes within 
the sample with differing anisotropies.
At present analysis of measurement data is currently con-
ducted using the techniques based on those described in [119–
121]. The development of AC susceptibility is a valuable tool 
for MNP analysis, with relevance to a wide variety of applica-
tions [80, 122]. A standardised approach to both measurement 
and analysis will provide great value to manufacturers.
A similar method to ACS is magnetorelaxometry (MRX), 
where the magnetic response versus time of an ensem-
ble of MNP is observed after switching off an external 
pre-magnetizing field (typically in the mT range). Devices 
have been demonstrated using both SQUID magnetometry 
[123–125], as well as fluxgate magnetometers [126, 127] 
which have the advantage of not requiring cryogenic cooling, 
and other techniques [128]. Applications of MRX are rap-
idly developing at present. The major topics at present can be 
divided into those which aim at (1) quantification and locali-
sation of MNPs administered to organisms, and (2) measure-
ments that probe the interactions of magnetic nanoparticles 
with their environ ments. An excellent overview of these appli-
cations is given in [129].
Rotating magnetic field (RMF) is a characterisation method 
with similarity to ACS, although the technique is still under 
development. It measures the viscous drag forces between the 
particles in a liquid dispersion and the carrier fluid in which 
they are dispersed [130, 131]. A constantly rotating magnetic 
field is applied to the sample at a range of frequencies. The 
system measures the phase lag between the field vector and 
the rotating moment of the particle ensemble via monitoring 
the real and imaginary components of the complex magnet-
isation. RMF allows the Brownian time constant of particles 
in suspension to be measured and it can also be used to probe 
the colloidal stability and binding state of the particles [132–
134]. It is also possible to find the magnetic moment of the 
particles, and if the saturation magnetisation is known, then 
the core size can also be determined.
6.2.3. Intrinsic loss power for magnetic heating. When an 
alternating magnetic field is applied to MNP suspensions, it 
is possible to observe heating within MNP suspensions. There 
are number of mechanisms that underpin this effect, includ-
ing the particle system used and the magnitude and frequency 
of the applied field. Magnetic hyperthermia therapy is based 
upon utilising the heat to cause damage to tumour cells that 
have been loaded with MNPs. A more complete discussion of 
the application can be found within section 8.1.2.1.
The effectiveness of a given particle type for magnetic 
hyperthermia therapy is characterised by the specific loss 
power (SLP), which is a measure of the heat which it dis-
sipates. The SLP of an MNP suspension describes the heat-
ing power P generated per unit mass of magnetic material m 
within it [135], and can be expressed as:
SLP =
P
m
.
While the heating power produced by a specific nanoparticle 
type is dictated by its physical and magnetic properties, the 
power produced also scales linearly with the frequency f and 
quadratically with the strength of the alternating magnetic 
field H applied (at low fields). The intrinsic loss power (ILP) 
of an MNP material attempts to remove these factors, and is 
given by:
ILP =
SLP
fH2
.
A quantitative and comparable measurement of these values is 
deceptively difficult to achieve, as indicated by the vast scatter 
of results published in the literature. One major hurdle is that 
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the majority of measurement setups are non-adiabatic, mean-
ing that heat is continuously lost from the MNP suspension 
during measurement. A number of techniques to compensate 
for these losses are currently under investigation [136]. More 
rarely, attempts are made to conduct measurements under adi-
abatic conditions [45, 137, 138], which requires a significant 
investment of both time and resources.
At present there is no standard methodology for measuring 
the SLP of MNP suspensions and the current state-of-the-art 
allows only for the direct comparison of particle efficiencies 
using identical equipment. The realisation of a safe, efficient 
and reliable cancer therapy based on magnetic hyperthermia 
will be significantly furthered by the creation of a standard-
ized methodology for characterizing the ILP of MNP systems 
[27, 135, 139–141].
6.2.4. NMR relaxivity measurements. The effectiveness of 
MNP suspensions as contrast agents is characterised using 
the NMR T1 and T2 parameters [142]. These describe the 
relaxation of hydrogen nuclei (i.e. protons) via the spin-lattice 
(longitudinal) relaxation and the spin-spin (transversal) relax-
ation, respectively, following the application a radio frequency 
pulse. These values are modified in the vicinity of MNPs due 
to magnetic field arising from the magnetic core [143, 144], 
although the spatial configuration of the core/core-cluster as 
well as and surface modifications of the particle is known to 
affect the relaxivity of protons [145, 146].
The relaxivity Ri of MNP suspensions is given by:
1
Ti
= Ri · c (Fe) + 1Ti(0) ,
where Ti represents either the longitudinal (T1) or transversal 
(T2) relaxation time in at a concentration c(Fe) in (mmol l−1) 
and the relaxation time Ti(0) of the pure solvent. A common 
testing method is to conduct T1 and T2 measurements for a 
series of concentrations of the same particle type, and com-
pare the results with the above relationship [147].
MNP suspensions are regularly used to modify the contrast 
in magnetic resonance imaging (MRI), a non-invasive in vivo 
imaging technique with a broad range of diagnostic applica-
tions. For a longer discussion of this technique and the key 
literature of relevance, please see section 8.1.1.1. It is worth 
noting that the technique by which magnetic resonance relax-
ivity is assessed is not yet universal, and a truly harmonised 
system for calibration and measurement protocols is needed.
6.2.5. Magnetic particle spectroscopy. In magnetic particle 
spectroscopy (MPS), a MNP sample is exposed to a sinusoi-
dally varying magnetic field at a specific excitation frequency 
(typically ca. 25 kHz). The excitation field has sufficient 
amplitude so as to exploit the nonlinearity of the magnet isation 
curve. The magnetic response is monitored using a single or 
gradiometric induction coil, while the measured signal is a 
convolution of the excitation frequency with higher odd har-
monics that are dictated by the nonlinear magnetisation curve 
of the MNP sample. It follows, then, that a Fourier transfor-
mation of the signal separates the harmonics of the MNPs and 
the signal originating from the excitation field. The observed 
spectrum depends on a variety of characteristic parameters of 
the MNPs, including the core and particle size distributions, 
the magnetic anisotropy, temperature as well as the frequency 
of the excitation field.
As a specific quantitative method, MPS is suited to charac-
terize the MNP content in a larger sample of biological mat-
erial. Standardization of this method has not been performed 
so far.
MPS is closely related to the recent innovation of magn-
etic particle imaging (MPI) [84], with both techniques pro-
portional to the non-linear magnetisation response of MNP 
suspensions [26]. Indeed, whilst MPS has great potential for 
the optimization of tracers for MPI, the results obtained by 
this technique are also influenced by properties of the suspen-
sion, such as the hydrodynamic size and the viscosity of the 
liquid in which they are suspended (if Brownian relaxation 
dominates) [148–150].
6.2.6. Magnetic separation (as a test of colloidal stability). 
Magnetic separation is a technique by which the stability 
of an MNP suspension in the presence of varying magnetic 
field gradients can be probed. The application of a magnetic 
field gradient to the MNP suspension results in a magnetic 
force, causing the MNPs to move towards high field regions. 
The velocity of the MNP is determined by a combination of 
the magnetic properties of the MNP and the hydrodynamic 
properties of the whole suspension, described by the viscos-
ity of the solvent, the hydrodynamic MNP diameter and the 
temperature, also taking stochastic Brownian motion of the 
particles into account [151, 152].
The MNP concentration is monitored by observing the 
intensity I of light transmitted through the suspension. 
Concentration c follows then the Beer–Lambert-Bougers 
relationship:
I = I0e−αLc,
where I0 is the light intensity transmitted in the absence of any 
particles, L is the length of the optical light path, and α is the 
absorption coefficient of the particle suspension.
Provided that the transmission intensity is appropriately 
calibrated using suspensions of known concentration, the evo-
lution of particle concentration under applied field gradients 
may be measured. A variety of field gradients can be applied 
in a typical system, with gradients up to 60 T m−1 commonly 
used [153].
This technique provides a suitable method to test MNP 
suspensions which would otherwise be stable over the meas-
urement time scales as well as assessing the stability against 
applied fields of a given particle system. Practically, magnetic 
separation utilizes typical sample volumes in the range of 40–
100 μl, and can probe MNP suspensions with concentrations 
ranging from 0.05 mgFe ml−1 up to 0.3 mgFe ml−1. Separation 
times are in the range of hours for most field gradients used.
Magnetic separation is also critical to a number of appli-
cations where MNPs have functional groups added to the 
surface in order to bind to specific target molecules [6]. 
The particles and attached material are then removed from 
the fluid by the application of a field gradient. Examples of 
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applications include the isolation and measurement of specific 
biomolecules, and the removal of pollutants from water (see 
section 8.1.3 for details).
Colloidal stability of a nanoparticle suspension is a key 
factor in determining its viability for a multitude of applica-
tions. As a result, the standardisation of this technique can be 
expected to have a strong positive impact on the industry. The 
implementation of round-robin measurements of known nano-
particle compositions may be used to compare the accuracy and 
reproducibility of measurements using different equipment.
7. MNP labelling standards
Appropriate labelling is of great importance for all products. 
The specific information included should be informative, 
appropriate and unambiguous for the customer. While the 
labelling requirements of a customer will be dictated by the 
application for which the particles are destined, it is necessary 
to discern the characteristics which are scientifically appropri-
ate for inclusion.
This requires commonly accepted definition of terms, 
specification of measurement procedures and expression 
of results. Especially for magnetic properties of MNP sus-
pensions, none of these conditions are readily available. 
Consequently, labels for marketed MNP-based products often 
contain only the chemical composition and a geometrical size 
parameter, under the title ‘magnetic’ or ‘superparamagnetic 
nanoparticles’. Quantitative magnetic properties are rarely 
indicated, for the above-mentioned reasons.
7.1. Coverage of published standards
Generalised information regarding the labelling of nanomat-
erials (not specifically particles) may be found in [154]. The 
document is short and non-specific, and thus it is of little rel-
evance for the particular requirements of MNP based indus-
tries. The content is intended to provide optional guidelines to 
be used at the user’s discretion. The overarching message is 
that, for the time being at least, any decision on the appropriate 
labelling content for nanomaterials should be agreed between 
the manufacturer and customer on a case-by-case basis. Work 
is currently being undertaken within ISO to provide a new 
version of the document with more information and coverage.
There are however more strict regulations for labelling 
chemical [155, 156] and medical products [157, 158]; with 
the main focus on occupational, environmental and end-user 
safety. Even these regulations are relevant to the major appli-
cation areas of MNPs, such as medical diagnostics and treat-
ment, none of them are directly connected to the magnetic 
properties of the products and therefore they are not scruti-
nized in this review.
7.2. Standardisation requirements
A key topic in developing future standardisation on MNPs is 
to establish the terms and definitions that could potentially be 
used on labels for MNP suspensions. MNPs possess many 
physical parameters that are relevant for certain application, 
but it would not make sense to list them all on each label. Thus, 
the precise requirements for labelling should be dictated by 
the needs of the end-user, in a mix-and-match approach. Some 
of this information may be deduced from currently available 
knowledge, while in some cases additional studies may be 
required in order to ascertain the necessary understanding. 
Nonetheless, an exhaustive list of all of the potentially valid 
parameters should be established. This list should enter the 
content of a labelling standard for MNP. The parameters on 
this list should be metrologically assessed measurands, with 
published standards for best practice in conducting their mea-
surement. With a framework available to indicate the valid 
parameters which are scientifically valid for use in labelling, 
the manufacturer and user can then agree on those parameters 
from the list which are necessary when supplying a particle 
suspension for a specific purpose.
8. MNP applications standards
At this point we turn our attention to an examination of the cur-
rent state of applications of MNPs and MNP suspensions. There 
are currently no standards (at either national or international 
level) that stipulate the requirements necessary for the char-
acterisation of MNPs for any specific end-user technologies, 
which is hardly surprising given the lack of standardisation in 
vocabulary, methods, and measurement techniques. Moreover, 
many of the technologies are themselves still developing, which 
in itself also contributes to lack of established documenta-
tion. However, the development and adoption of standards to 
stipulate the language, characterisation methods and appropri-
ate labelling of MNPs for specific purposes will only serve to 
accelerate the development and approval of new MNP-based 
products intended for clinical and technological purposes.
MNP suspensions designed for use in medical applica-
tions are subject to particularly stringent testing by regula-
tory bodies (such as the Food and Drug Administration, or the 
European Medicines Agency) before they can be administered 
for any market by regulatory bodies. Regulatory approval may 
be eased if the product proposed for approval has been manu-
factured and characterised according to established stand-
ards. Therefore, the development of a body of work using the 
‘mix-and-match’ approach proposed in section  2 is antici-
pated to greatly facilitate the approval and uptake of MNP 
based medicine and technologies across the world.
In the following, we will give a brief description of some 
of the key innovative technologies which are in the process 
of implementing MNPs along with some discussion of their 
major requirements in terms of characterisation and future 
standardisation.
8.1. Emerging applications and their standardisation  
requirements
8.1.1. Medical imaging techniques. Magnetic nanoparticles 
find uses in medical imaging as both contrast agents in MRI, 
and as tracers in MPI. Imaging technologies are not limited to 
magnetic nanoparticles; gold nanoparticles and nanorods are 
used in photoacoustic imaging, whilst radioactive tracers are 
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used to generate contrast in positron emission tomography. 
However, MNPs offer high spatial resolution and so make a 
good contrast agent for use in MRI. The contrast arises from 
the very nature of the magnetism within the nanomaterial. 
In the case of MPI imaging, the imaging signal arises from 
the induced magnetisation measured directly from the MNP 
tracer within the imaging medium. The minimally invasive 
nature of both of these techniques, combined with the insights 
which they provide, make them powerful tools in current and 
future diagnostics. We discuss the two key applications, and 
refer to the key measurements outlined in sections 6.2.2, 6.2.4 
and 6.2.5.
8.1.1.1. Magnetic resonance imaging (MRI). Magnetic reso-
nance imaging is non-invasive and non-ionising imaging 
technique with the potential to provide high contrast images 
of living tissue (and also blood flow) with accessible spatial 
resolutions of 50 μm or smaller, providing high-quality in vivo 
imaging of both healthy and diseased soft tissue and organs. 
These advantages have resulted in the technique becoming an 
invaluable tool to medical professionals.
MRI is based upon the NMR principle as discussed pre-
viously (section 6.2.4). The imaging contrast arises from the 
protons in water molecules. Thus, due to differences in the 
water to fat ratio, organs and tissue within the body provide 
a natural contrast within the body, from which images can 
be reconstructed based upon the different relaxivities. MRI 
systems commonly implement large magnetic fields (3 T or 
more).
Nanoparticles are regularly employed as contrast agents, 
either by increasing the T1 signal (commonly known as posi-
tive contrast agents, such as paramagnetic material like Gd) 
or by reducing the T2 signal (often called a negative contrast 
agent, such as superparamagnetic nanoparticles, like iron 
oxide, [159–161]). The negative contrast offered by FeO par-
ticles often limits their use in tissues which have low intrin-
sic T2 signals (e.g. lung tissue). To circumnavigate this issue, 
innovative techniques based on either pulse sequences [162, 
163], or the engineering of ultrasmall MNPs with positive 
T1 contrast [164] are being developed. Further advances in 
resolution and sensitivity of T2 agents may be offered by the 
use of more complex metallic ferrites including CoFe2O4 and 
NiFe2O4. However, there are issues regarding toxicity and the 
long term effects of introducing cobalt and nickel based nano-
particulate materials into the body, and these materials are not 
yet approved for use in humans. Widespread adoption of these 
new materials will depend upon the evaluation of their long-
term health impact and elimination from the body.
While a significant number of standards exist which cover 
the safety of the MRI [165–171]; none have yet been pub-
lished to address the use of magnetic nanoparticle based con-
trast agents [172].
8.1.1.2. Magnetic particle imaging. Magnetic particle imag-
ing has great potential as a technique for minimally invasive 
in vivo imaging. Briefly, the principle of the technique is based 
upon the reconstruction of the spatial distribution (concentra-
tion) of a MNP tracer within the medium to be imaged [84].
To achieve this, a sinusoidal AC magnetic field (drive-field) 
typically around 25 kHz frequency is used to excite the MNPs 
with the sample, and the induced magnetisation is measured 
using pick-up coils. Due to the nonlinear magnetisation curve 
of the MNPs, the Fourier transform of the induced magnet-
isation signal contains additional higher-harmonics of the 
drive-field waveform. Analysis of these higher harmonics 
provides a MNP-specific imaging signal free from any back-
ground (tissue) contributions.
To provide spatial encoding of the MNP signal, a (quasi-) 
static magnetic field gradient is applied to the sample in order 
to saturate the MNPs across the majority of the volume to 
be imaged. This saturating field drops to zero within a small 
region known as the field free point (FFP). The FFP is scanned 
across the imaging volume and the magnetic response from 
each region (voxel) is recorded.
The spatially dependent harmonic data can be recon-
structed into an image of the MNP density distribution via 
one of two methods. In the system function (SF) based tech-
nique [4], the scanner response to a small sample of tracer is 
mapped for all possible locations within the imaging volume. 
Reconstruction of imaging data is conducted by an inversion 
process; the spectra measured during the imaging measure-
ment, and the accompanying system function, are used to find 
the concentration of MNPs within each region during the MPI 
measurement. Alternatively, X-space reconstruction requires 
no SF measurement [173, 174], and avoids the noise which 
forms an intrinsic part of a SF measurement; however, addi-
tional details about the passage of the FFP through the sample 
space are required in order to implement it.
 The underlying physics of MPI is very similar to that of 
MPS [175], a technique which is discussed in section 6.2.5 of 
this document. The potential of this imaging modality for use 
in medical and biological studies was established in 2009 by 
the real-time in vivo imaging of a mouse’s heart [176].
A key task in the development of MPI for clinical use is 
the development of safe, optimised tracer materials based on 
MNPs in liquid dispersion. Key factors of consideration in 
assessing a potential tracer are the general magnetic properties 
[177–179], the stability of the particles in dispersion, espe-
cially under applied fields, and finally the proving the perfor-
mance by imaging objects or organs in animals.
It is a major task for the future to define a standardized way 
of describing the imaging performance of MPI tracers. There 
exists a variety of MPI scanner principles, readout methodolo-
gies and image reconstruction approaches [180–184]. In order 
to obtain a standardized assessment of the imaging perfor-
mance, it will be necessary to consider the actual concentration 
of the MPI tracers and the signal to noise level as well as other 
parameters of the MPI scanner [185]. Furthermore, a clear 
physical description of the relation between magnetic proper-
ties of MPI tracers and the imaging resolution is needed [186].
8.1.2. Biological and therapeutic applications. Therapeutic 
applications of MNP suspensions span a broad market and 
includes magnetic hyperthermia therapy [194], targeted drug 
delivery [187, 188], gene delivery [189], and the stimulation/
suppression of the human immune system [190–192]. Despite 
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the differences in the physical principles of therapy, standardi-
sation of technical terms as well as the synthesis and charac-
terisation methods would provide a reliable understanding of 
the MNP properties [27, 193] which benefit them all.
8.1.2.1. Magnetic hyperthermia therapy. Magnetic hyperther-
mia therapy has the potential to impact the methodology used 
to treat a variety of cancers within humans. This is achieved 
by targeting functionalised MNP solutions, as well as high 
frequency AC fields, at specific cancerous organs in order to 
create local heating to damage the tumour tissue. Successful 
magnetic hyperthermia trials have been reported in animal 
models [194], and more recently, successful clinical trials 
are under way conducted using NanoTherm™ particles at the 
Charité Hosptial (Berlin, Germany) [195, 196]. As the number 
of companies entering this market continues to increase, we 
expect competition to drive the development of both labora-
tory based and clinical equipment.
The ability of MNP solutions to dissipate heat per unit mass 
of magnetic material (SLP, ILP) are key requirement in craft-
ing safe efficient treatments; however, a number of other par-
ticle parameters must also be properly determined before the 
particles can be administered and the procedure conducted in 
vivo. Examples of these include the verification of the particle 
sizes, establishing superparamagnetic behaviour and chemical 
composition (impurities increase toxicity).
Also, the metrology in the determination of heat generation 
is currently purpose of intensive research activities [139, 197].
8.1.2.2. Diagnostic applications/molecular sensing. By 
far the most established industry at present is the isolation, 
detection and/or removal of specific biomolecules using 
functionalised MNP suspensions. For detailed discussion of 
the techniques, we refer the reader to a number of excellent 
reviews already published on the subject [198–202]. Briefly, 
the technique relies upon the tethering of MNP labels to target 
molecules via the use of suitable functionalised MNP coat-
ings. Once the particle label is linked to the target, a number of 
options are possible. The MNPs and their attached cargo may 
then be extracted into a smaller volume using magnetic field 
gradients, to either concentrate the target analyte for detection 
of low concentrations, or else to clean the wider sample solu-
tion of the target molecule.
A large number of diagnostic systems currently available 
on the market are based on this type of magnetic immuno-
assay technology, with some large corporations (e.g. Roche 
Diagnostics, Abbott) already producing well established diag-
nostic products. These products commonly implement well 
established micrometer sized magnetic beads which are large 
multicore MNPs, two major manufacturers of these beads are 
Thermo Fisher Scientific and Merck. It follows, then, that any 
move towards standardisation should be conducted in close 
liaison with the major companies involved.
Magnetic particle spectroscopy has been demonstrated as 
a potential method for probing the binding state of nanoparti-
cles within biological samples, by monitoring the reduction of 
rotational freedom of functionalised MNPs as a way to estab-
lish whether or not they have bound to target biomolecules 
[203, 204]. This technique has been shown to be sensitive to 
the detection of blood clots, by monitoring the presence of 
thrombin, a biomolecule released during the clotting process 
[205]. Whilst further work is necessary to establish the detec-
tion limits of this application, it has great potential to revo-
lutionise the detection and treatment of deep vein thrombosis, 
a potentially life-threatening medical condition. Though the 
MPS technique is an active topic in scientific research, no 
standardisation has been developed so far.
8.1.3. Environmental remediation and engineering based 
applications. Magnetic nanoparticle suspensions form the 
cornerstone of a number of innovative techniques to aid in the 
desalination of seawater and the removal of heavy metal pol-
lutants. With increasing global attention on sustainability and 
environmental protection this field can be expected to grow 
dramatically in the coming years. The requirements for MNPs 
for use in environmental application, as catalysts or in seals, 
lubricants and soaps are not, in general, as demanding as for 
other applications such as biomedical use. However, standards 
may help to improve and push the development of new prod-
ucts using the unique properties of MNPs, to make the appli-
cation more reliable and to gain their acceptance in society. A 
summary of some of the most promising methods currently 
under development can be found below.
8.1.3.1. Forward osmosis and seawater desalination. The 
desalination of sea water is a key opportunity for relieving 
strain on resources in water-stressed regions across the globe 
[206]. Realisation of this technology requires the minimisa-
tion of energy consumption in the desalination process. For-
ward osmosis is capable of producing an easily-cleaned liquid 
with a higher osmotic pressure (draw solution) than the sea-
water. Briefly, the two solutions are separated by a thin semi-
permeable membrane across which the water molecules can 
osmose. Water molecules diffuse from the sea water into the 
more concentrated draw solution, leaving behind the salts and 
impurities which are too large to traverse the membrane. After 
the osmosis process has ended, the draw solution is cleaned 
and the resulting fresh water is ready for use.
MNP suspensions offer unique opportunities for manufac-
turing draw solutions since the particles can be quickly and 
easily separated from the osmosed fluid via the application of 
external magnetic fields [207]. Surface functionalisation and 
particle sizes have both been demonstrated to influence their 
efficiency as a draw solutes [208, 209]. Additional efficiency 
has recently been demonstrated by implementing magnetic 
nanoparticles with thermosensitive coatings [210, 211], thus 
allowing the same solute to be reused multiple times in the 
preparation of fresh draw solutions.
8.1.3.2. Heavy metal ion removal. MNP suspensions have 
also been applied to the removal of toxic heavy metal pol-
lutants from water. Both bare and functionalised composite 
nanoparticles have been shown to completely remove aqueous 
chromium ions and arsenic, [212–214], with the potential to 
benefit the clean-up of industrial pollution arising from mining 
and manufacturing industries. However, in these applications 
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it is more the large surface and specific chemical activity of 
MNPs that are the most important parameters, rather than 
their magnetic behaviour, and other non-magnetic nanopar-
ticle solutions may be equally as viable. It remains to be seen 
whether a standardization of magnetic properties of MNP and 
MNP solutions will directly benefit such applications.
8.1.3.3. Catalysts for industrial reactions. The surface func-
tionalisation of MNP solutions has led to their use as cata-
lysts in reactions, such as in synthesis of biodiesel fuel [215]. 
Specific functionalisation of the particle surface provides a 
huge active surface area, with colloidal dispersion of MNP 
providing a homogeneous distribution of the catalyst through-
out the reactant liquid, and finally the magnetic core meaning 
the material can be easily separated of the material following 
completion of the reaction.
8.1.4. Seals, lubricants and soaps. Magnetic nanoparticles 
in liquid suspension have been demonstrated for use in vac-
uum seals with products currently available from companies 
including Ferrotec and Roseal. The products are commonly 
described as ferrofluids or magnetic liquids. They are suit-
able for use in high-vacuum environments, in cases where it is 
necessary to facilitate rotation and movement of components 
[216–218].
The incorporation of MNP suspensions into lubricants 
allows precision targeting of the location of these materials 
[219, 220], which is of particular interest for the development 
of highly resilient and long-running precision mechanisms. In 
a similar way, the incorporation of MNP and MNP suspen-
sions into soaps has the potential to aid a variety of applica-
tions including the clean-up of oil spills [221].
9. Standardisation work underway and future needs 
of industry
Although individual measurements of the characteristics of 
MNPs and MNP suspension are well established in the scien-
tific literature, there is a lack of cross-laboratory compariso ns 
of MNP metrology. The circulation of standard reference 
samples for ‘round-robin’ style interlaboratory comparison 
measurements, and comparisons of multiple measurement 
techniques which probe the same characteristic are a neces-
sary ongoing task. This type of comparative work between 
different measurement laboratories forms a key aspect of 
pre-normative work in the development of new standards (as 
specified by the metrological check-list). It is a task for the 
physics and metrological communities to conduct these con-
sistency checks within the coming years. Two major research 
collaborations are currently being undertaken to further these 
goals. The NanoMag project aims to standardize, improve 
and redefine analysis methods for magnetic nanoparticles [9], 
while the RADIOMAG project works towards uniting experts 
and harmonising technologies in the fields of magnetic hyper-
thermia and indirect radiation therapy [139].
In addition to the numerous published standards listed in 
the previous sections, a number of standardization bodies 
are currently assessing the need for, and feasibility of, new 
standards in the field of nanotechnology. Indeed, ISO is cur-
rently developing two work items relating to MNP suspen-
sions: ISO 19807 [222] and ISO TC/229 N 1421 [223]. The 
first of these is a draft material specification with the aim 
of providing coverage relevant to all types of MNP suspen-
sions, and aims to introduce some of the unique terminology 
required by the field, whilst collate existing ISO standards of 
relevance and specifying the characterisation measurements 
which may be appropriate for use. The latter is an example 
of an early stage application standard which has recently 
been introduced to the ISO/TC 229 work list, and aims is to 
provide guidelines for MNP and MNP suspensions that are 
destined for the separation of circulating tumour DNA from 
biological samples and which is a subsection of the wider 
group of methods for magnetic separation of target mol-
ecules using functionalised MNPs. Such draft documents 
represent the first steps of standardisation into the field of 
MNP suspensions and we expect the list of documents under 
development can be expected to expand significantly in the 
coming years.
10. Conclusion
Significant advances have recently been made in the devel-
opment of MNPs tailored to meet the needs of emerging 
end-user technologies. While progress has been made in our 
understanding of the underlying physics of these systems, 
much work is still required. Manufacturing techniques con-
tinue to improve in their reproducibility and yields; however, 
results still fall short of industry requirements. Similarly, 
great advances have been made in a variety of characteri-
sation measurements and accompanying particle models, 
 however there is currently a lack of consistency checking 
between different laboratories and measurement techniques. 
While a number of studies are currently in progress to inves-
tigate specific aspects of MNP characterisation [152, 153], a 
formidable task remains in order to demonstrate agreement 
between different types of MNP characterisation measure-
ments. These tasks include proving the invariance of results 
obtained using the same measurement technique in differ-
ent laboratories, and also the consistency of using different 
characterisation techniques to probe the same parameter of 
a MNP sample. The article is intended to serve as a precur-
sor to future standards developments relating to MNPs in liq-
uid suspension. It outlines the major topics in contemporary 
nanoparticle development which deserve to receive attention 
in the development of harmonised terminology, measurement 
techniques and health and safety for MNP products. By pre-
senting an overview of these unsolved questions and obstacles 
to progress, we intend to provide a resource for identifying 
future topics for research, and a roadmap for future develop-
ment within this field.
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
20
Acknowledgment
Financial support from the European Commission Framework 
Programme 7 under grant agreement No. 604448 ‘NanoMag’, 
and the DFG project ‘QuantMPI: Establishment of quantita-
tive Magnetic Particle Imaging (MPI) application orientated 
phantoms for preclinical investigations’ (grant TR 408/9-1) 
are gratefully acknowledged.
References
	 [1]	 Zahn M 2001 Magnetic fluid and nanoparticle applications to 
nanotechnology J. Nanopart. Res. 3 73–8
	 [2]	 Torres-Díaz I and Rinaldi C 2014 Recent progress in 
ferrofluids research: novel applications of magnetically 
controllable and tunable fluids Soft Matter 10 8584–602
	 [3]	 Raj K, Moskowitz B and Casciari R 1995 Advances in 
ferrofluid technology J. Magn. Magn. Mater. 149 174–80
	 [4]	 Ito A, Shinkai M, Honda H and Kobayashi T 2005 Medical 
application of functionalized magnetic nanoparticles 
J. Biosci. Bioeng. 100 1–11
	 [5]	 Plouffe B D, Murthy S K and Lewis L H 2014 Fundamentals 
and application of magnetic particles in cell isolation and 
enrichment: a review Rep. Prog. Phys. 78 16601
	 [6]	 Borlido L, Azevedo A M, Roque A C A and Aires-Barros M R 
2013 Magnetic separations in biotechnology Biotechnol. 
Adv. 31 1374–85
	 [7]	 Choi J and Wang N S 2011 Nanoparticles in biomedical 
applications and their safety concerns Biomedical 
Engineering—From Theory to Applications (Rijeka: 
InTech) pp 299–314
	 [8]	 Mansfield E, Kaiser D L, Fujita D and Van de Voorde M (ed) 
2017 Metrology and Standardisation for Nanotechnology—
Protocols and Industrial Innovations (New York: Wiley) 
(https://doi.org/10.1002/9783527800308)
	 [9]	 RISE Acreo 2013 www.nanomag-project.eu/
	[10]	 Bogren S et al 2015 Classification of magnetic nanoparticle 
systems—synthesis, standardization and analysis methods 
in the nanomag project Int. J. Mol. Sci. 16 20308–25
	[11]	 Gutiérrez L et al 2015 Synthesis methods to prepare single- 
and multi-core iron oxide nanoparticles for biomedical 
applications Dalt. Trans. 7 2943–52
	[12]	 ISO/TS 2013 Nanotechnologies—vocabulary—part 8: 
nanomanufacturing processes 80004-8:2013
	[13]	 ISO 2011 Guidelines for auditing management systems 
19011:2011
	[14]	 ISO 2009 Managing for the sustained success of an 
organization—a quality management approach 9004:2009
	[15]	 ISO 2015 Quality management systems—requirements 
9001:2015
	[16]	 ISO 2015 Quality management systems—fundamentals and 
vocabulary 9000:2015
	[17]	 ISO/AWI TR General framework for the development of 
occupational exposure limits for nano-objects and their 
aggregates and agglomerates 18637
	[18]	 ISO/TR 2008 Nanotechnologies—health and safety practices 
in occupational settings relevant to nanotechnologies 
12885:2008
	[19]	 ISO/TS 2012 Nanotechnologies—occupational risk 
management applied to engineered nanomaterials—part 1: 
principles and approaches 12901-1:2012
	[20]	 ISO/TS 2014 Nanotechnologies—occupational risk 
management applied to engineered nanomaterials—part 2: 
use of the control banding approach 2901-2:2014
	[21]	 ISO/TR 2011 Nanotechnologies—nanomaterial risk evaluation 
13121:2011
	[22]	 ISO/TR 2012 Nanomaterials—preparation of material safety 
data sheet (MSDS) 13329:2012
	[23]	 Murashov V and Howard J 2011 Nanotechnology Standards 
(Berlin: Springer)
	[24]	 Baaziz W et al 2014 Magnetic iron oxide nanoparticles: 
reproducible tuning of the size and nanosized-dependent 
composition, defects, and spin canting J. Phys. Chem. C 
118 3795810
	[25]	 Posth O et al 2015 Classification of analysis methods for 
characterization of magnetic nanoparticle properties XXI 
IMEKO World Congress Measurement in Research and 
Industry
	[26]	 Biederer S et al 2009 Magnetization response spectroscopy 
of superparamagnetic nanoparticles for magnetic particle 
imaging J. Phys. D: Appl. Phys. 42 205007
	[27]	 Coïsson M et al 2016 Specific absorption rate determination 
of magnetic nanoparticles through hyperthermia 
measurements in non-adiabatic conditions J. Magn. Magn. 
Mater. 415 2–7
	[28]	 Abenojar E C, Wickramasinghe S, Bas-Concepcion J and 
Samia A C S 2016 Structural effects on the magnetic 
hyperthermia properties of iron oxide nanoparticles Prog. 
Nat. Sci. Mater. Int. 26 440–8
	[29]	 ISO/IEC Directives Part 2 2004 Rules for the Structure and 
Drafting of International Standards 5th edn (Geneva: ISO)
	[30]	 ISO/TC 2015 Nanotechnologies—framework for identifying 
vocabulary development for nanotechnology applications in 
human healthcare 17302:2015
	[31]	 ISO/TC 229 N 673 2007 Metrological checklist (Geneva: ISO)
	[32]	 JCGM 2002012 2008 International vocabulary of metrology—
basic and general concepts and associated terms (VIM)  
vol 41 3rd edn
	[33]	 Wang C-Y, Pan S-P, Peng G-S and Tsai J-H 2005 A 
comparison study on the measurement of nanoparticles 
Proc. SPIE 5879 323–8
	[34]	 Gollwitzer C et al 2016 A comparison of techniques for size 
measurement of nanoparticles in cell culture medium Anal. 
Methods 8  5272–82
	[35]	 Ludwig F et al 2017 Size analysis of single-core magnetic 
nanoparticles J. Magn. Magn. Mater. 427 19–24
	[36]	 Ludwig F, Wawrzik T and Schilling M 2012 Characterization 
of magnetic nanoparticles for magnetic particle 
imaging by magnetorelaxometry, AC susceptibility, 
magnetic particle spectroscopy and static magnetization 
measurements Magnetic Particle Imaging Springer 
Proc. in Physics (Berlin: Springer) vol 140 (https://doi.
org/10.1007/978-3-642-24133-8_6)
	[37]	 Bødker F, Hansen M F, Koch C B, Lefmann K and Mørup S 
2000 Magnetic properties of hematite nanoparticles Phys. 
Rev. B 61 6826–38
	[38]	 Bender P et al 2017 Structural and magnetic properties of 
multi-core nanoparticles analysed using a generalised 
numerical inversion method Sci. Rep. 7 45990
	[39]	 Hole P et al 2013 Interlaboratory comparison of size 
measurements on nanoparticles using nanoparticle tracking 
analysis (NTA) J. Nanoparticle Res. 15 2101
	[40]	 Freiman S 2017 Versailles Project on Advanced Materials 
and Standards (VAMAS) Metrology and Standardization 
of Nanotechnology: Protocols and Industrial Innovations 
(Weinheim: Wiley)
	[41]	 Strnat R, Hall R and Masteller M 2007 Precision and accuracy 
study on measurement of soft magnetic properties using DC 
hysteresigraphs IEEE Trans. Magn. 43 1884–7
	[42]	 Tholen D 2011 Metrology in service of society: the role of 
proficiency testing Accredit. Qual. Assur. 16 603–5
	[43]	 ISO/IEC 2010 Conformity assessment—general requirements 
for proficiency testing 17043:2010
	[44]	 Fock J, Bogart L K, Posth O, Hansen M F, Pankhurst Q A and 
Frandsen C 2016 Uncertainty budget for determinations 
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
21
of mean isomer shift from Mössbauer spectra Hyperfine 
Interact. 237 1–11
	[45]	 Andreu I and Natividad E 2013 Accuracy of available methods 
for quantifying the heat power generation of nanoparticles 
for magnetic hyperthermia Int. J. Hyperth. 29 739–51
	[46]	 ISO 2008 Uncertainty of measurement—part 3: guide to the 
expression of uncertainty in measurement (GUM:1995)  
p 130 Guide 98 3
	[47]	 PD CEN ISO/TS 2015 Technical specification. 
Nanotechnology—nanoparticles in powder form—
characteristics and measurements (Geneva: ISO) 
17200:2015
	[48]	 ISO 2013 Particle characterisation of particulate systems—
vocabulary (Geneva: ISO) 26824:2013
	[49]	 PD ISO/TR 2014 Nanotechnologies—considerations for the 
development of chemical nomenclature for selected nano-
objects (Geneva: ISO) 14786
	[50]	 Bean C P and Livingston J D 1959 Superparamagnetism 
J. Appl. Phys. 30 S120–9
	[51]	 Tran N and Webster T J 2010 Magnetic nanoparticles: biomedical 
applications and challenges J. Mater. Chem. 20 8760
	[52]	 Vatta L L, Sanderson R D and Koch K R 2006 Magnetic 
nanoparticles	: properties and potential applications Adv. 
Mater. 78 1793–801
	[53]	 Feijoo S, González-García S, Moldes-Diz Y,  
Vazquez-Vazquez C, Feijoo G and Moreira M T 2017 
Comparative life cycle assessment of different synthesis 
routes of magnetic nanoparticles J. Clean. Prod. 
143 528–38
	[54]	 Ayala V, Herrera A P, Latorre-Esteves M, Torres-Lugo M and 
Rinaldi C 2013 Effect of surface charge on the colloidal 
stability and in vitro uptake of carboxymethyl dextran-
coated iron oxide nanoparticles J. Nanopart. Res. 15 1874
	[55]	 Laurent S et al 2008 Magnetic iron oxide nanoparticles: 
synthesis, stabilization, vectorization, physicochemical 
characterizations, and biological applications Chem. Rev. 
108 2064–110
	[56]	 Moore T L et al 2015 Nanoparticle colloidal stability in cell 
culture media and impact on cellular interactions Chem. 
Soc. Rev. 44 6287–305
	[57]	 Lin C-A J et al Design of an amphiphilic polymer for 
nanoparticle coating and functionalization Small 4 334–41
	[58]	 Sperling R A and Parak W J 2010 Surface modification, 
functionalization and bioconjugation of colloidal inorganic 
nanoparticles Phil. Trans. A 368 1333–83
	[59]	 Weidner A et al 2015 Preparation of core-shell hybrid 
materials by producing a protein corona around magnetic 
nanoparticles Nanoscale Res. Lett. 10 282
	[60]	 Hugounenq P et al 2012 Iron oxide monocrystalline 
nanoflowers for highly efficient magnetic hyperthermia 
J. Phys. Chem. C 116 15702–12
	[61]	 Hu F, Macrenaris K W, Waters E A, Schultz-Sikma E A, 
Eckermann A L and Meade T J 2010 Highly dispersible, 
superparamagnetic magnetite nanoflowers for magnetic 
resonance imaging Chem. Commun. 46 73–5
	[62]	 Blanco-Andujar C, Ortega D, Southern P, Pankhurst Q A 
and Thanh N T K 2015 High performance multi-core iron 
oxide nanoparticles for magnetic hyperthermia: microwave 
synthesis, and the role of core-to-core interactions 
Nanoscale 7 1768–75
	[63]	Eberbeck D, Dennis C L, Huls N F, Krycka K L, Gruttner C 
and Westphal F 2013 Multicore magnetic nanoparticles 
for magnetic particle imaging IEEE Trans. Magn. 
49 269–74
	[64]	 Sugimoto T 1989 Preparation and characterization of 
monodispersed colloidal particles MRS Bull. 14 23–8
	[65]	 Sugimoto T 2001 Monodispersed Particles (Amsterdam: 
Elsevier)
	[66]	 ISO 1996 Methods for determination of particle size 
distribution—part 8: photon correlation spectroscopy 
(Geneva: ISO) 13321:1996
	[67]	 ISO 2008 Particle size analysis—dynamic light scattering 
(Geneva: ISO) 22412:2008
	[68]	 Schmidt D, Eberbeck D, Steinhoff U and Wiekhorst F 
2016 Finding the magnetic size distribution of magnetic 
nanoparticles from magnetization measurements via the 
iterative Kaczmarz algorithm J. Magn. Magn. Mater. 
431 33–7
	[69]	 Wetterskog E, Castro A, Zeng L, Petronis S, Heinke D, 
Olsson E and Svedlindh P 2017 Size and property 
bimodality in magnetic nanoparticle dispersions: single 
domain particles versus strongly coupled nanoclusters 
Nanoscale 9 4227–35
	[70]	 Nobbmann U 2017 www.materials-talks.com/blog/2014/01/23/
intensity-volume-number-which-size-is-correct/
	[71]	 Eberbeck D, Wiekhorst F, Steinhoff U and Trahms L 
2006 Aggregation behaviour of magnetic nanoparticle 
suspensions investigated by magnetorelaxometry J. Phys. 
Condens. Matter 18 S2829–46
	[72]	 Khandhar A P, Ferguson R M and Krishnan K M 2011 
Monodispersed magnetite nanoparticles optimized for 
magnetic fluid hyperthermia: implications in biological 
systems J. Appl. Phys. 109 07B310
	[73]	 Mahmoudi M, Hofmann H, Rothen-Rutishauser B and  
Petri-Fink A 2012 Assessing the in vitro and in vivo toxicity 
of superparamagnetic iron oxide nanoparticles Chem. Rev. 
112 2323–38
	[74]	 Jun Y W, Seo J W and Cheon J 2008 Nanoscaling laws 
of magnetic nanoparticles and their applicabilities in 
biomedical sciences Acc. Chem. Res. 41 179–89
	[75]	 Hofmann-Amtenbrink M, von Rechenberg B and Hofmann H 
2009 Superparamagnetic nanoparticles for biomedical 
applications Nanostructured Materials for Biomedical 
Applications (Kerala: Transworld Research Network)  
pp 119–49
	[76]	 Neuberger T, Schopf B, Hofmann H, Hofmann M and 
Vonrechenberg B, Superparamagnetic nanoparticles for 
biomedical applications: possibilities and limitations 
of a new drug delivery system J. Magn. Magn. Mater. 
293 483–96
	[77]	 Néel M L 1949 Théorie du traînage magnétique des 
ferromagnétiques en grains fins avec application aux terres 
cuites Ann. Geophys. 5 99–136
	[78]	 Ferguson R M, Khandhar A P, Jonasson C, Blomgren J, 
Johansson C and Krishnan K M 2013 Size-dependent 
relaxation properties of monodisperse magnetite 
nanoparticles measured over seven decades of frequency by 
ac susceptometry IEEE Trans. Magn. 49 3441–4
	[79]	 Astalan A P, Ahrentorp F, Johansson C, Larsson K and 
Krozer A 2004 Biomolecular reactions studied using 
changes in Brownian rotation dynamics of magnetic 
particles Biosens. Bioelectron. 19 945–51
	[80]	 de la Torre T Z G et al 2011 Detection of rolling circle 
amplified DNA molecules using probe-tagged magnetic 
nanobeads in a portable AC susceptometer Biosens. 
Bioelectron. 29 195–9
	[81]	 Eberbeck D et al 2009 Specific binding of magnetic 
nanoparticle probes to platelets in whole blood  
detected by magnetorelaxometry J. Magn. Magn. Mater. 
321 1617–20
	[82]	 Ludwig F, Mäuselein S, Heim E and Schilling M 2005 
Magnetorelaxometry of magnetic nanoparticles in 
magnetically unshielded environment utilizing a differential 
fluxgate arrangement Rev. Sci. Instrum. 76 1–3
	[83]	 Dutz S and Hergt R 2014 Magnetic particle hyperthermia—a 
promising tumour therapy? Nanotechnology 25 452001
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
22
	 [84]	 Gleich B and Weizenecker J 2005 Tomographic imaging 
using the nonlinear response of magnetic particles Nature 
435 1214–7
	 [85]	 Felton C, Karmakar A, Gartia Y, Ramidi P, Biris A S and 
Ghosh A 2014 Magnetic nanoparticles as contrast agents 
in biomedical imaging: recent advances in iron- and 
manganese-based magnetic nanoparticles Drug Metab. 
Rev. 46 142–54
	 [86]	 Mørup S, Hansen M F and Frandsen C 2010 Magnetic 
interactions between nanoparticles Beilstein J. Nanotechnol. 
1 182–90
	 [87]	 Hansen M F and Mørup S 1998 Models for the dynamics of 
interacting magnetic nanoparticles J. Magn. Magn. Mater. 
184 L262–74
	 [88]	 Branquinho L C et al 2013 Effect of magnetic dipolar 
interactions on nanoparticle heating efficiency: 
implications for cancer hyperthermia Sci. Rep. 3 2887
	 [89]	 Landi G 2014 Role of dipolar interaction in magnetic 
hyperthermia Phys. Rev. B 89 14403
	 [90]	 Salas G et al 2014 Modulation of magnetic heating via 
dipolar magnetic interactions in monodisperse and 
crystalline iron oxide nanoparticles J. Phys. Chem. C 
118 19985–94
	 [91]	 Haase C and Nowak U 2012 Role of dipole-dipole 
interactions for hyperthermia heating of magnetic 
nanoparticle ensembles Phys. Rev. B 85 045435
	 [92]	 Batista E, Filipe E and Mickan B 2008 Volume calibration 
of 1000	μl micropipettes. Inter-laboratory comparison 
Accredit. Qual. Assur. 13 261–6
	 [93]	 Reichmuth A, Wunderli S, Weber M and Meyer V R 2004 
The uncertainty of weighing data obtained with electronic 
analytical balances Microchim. Acta 148 133–41
	 [94]	 ISO 2007 Particulate materials—sampling and sample 
splitting for the determination of particulate properties 
(Geneva: ISO) 14488:2007
	 [95]	 BS 1986 Methods for determination of particle size 
distribution—part 1: guide to powder sampling 3406-1
	 [96]	 ISO 2013 Paints, varnishes and raw materials for paints and 
varnishes—sampling (Geneva: ISO) 15528:2013
	 [97]	 ISO/TS 2012 Nanomaterials—quantification of nano- 
object release from powders by generation of aerosols 
(Geneva: ISO) 12025
	 [98]	 Calzolai L, Gilliland D, Garcìa C P and Rossi F 2011 
Separation and characterization of gold nanoparticle 
mixtures by flow-field-flow fractionation J. Chromatogr. A 
1218 4234–9
	 [99]	 ISO 2014 Particle size analysis—image analysis methods—part 
1: static image analysis methods (Geneva: ISO) 13322-1
	[100]	 EN 2003 Non-destructive testing—x-ray diffraction from 
polycrystalline and amorphous materials (Chiswick: BSI) 
13925-1:2003 (https://doi.org/10.3403/BSEN13925)
	[101]	 ISO 2015 Particle size analysis—small-angle x-ray scattering 
(Geneva: ISO) 17867:2015
	[102]	 ISO 2012 Colloidal systems—methods for zetapotential 
determination (Geneva: ISO) 13099
	[103]	 ISO 2006 Water quality—application of inductively coupled 
plasma mass spectrometry (Geneva: ISO) 17294:2006
	[104]	 ISO 2007 Water quality—determination of selected 
elements by inductively coupled plasma optical emission 
spectrometry (ICP-OES) (Geneva: ISO) 11885:2007
	[105]	 ISO/TS 2011 Nanotechnologies—determination of elemental 
impurities in samples of carbon nanotubes using 
inductively coupled plasma mass spectrometry (Geneva: 
ISO) 13278:2011
	[106]	 ISO/DTS 2017 Nanoparticles—detection and sizing of 
nanoparticles in aqueous media via single particle 
inductively coupled plasma mass spectrometry 19590
	[107]	 ISO 2014 Representation of results of particle size analysis 
(Geneva: ISO) 9276
	[108]	 PD ISO/TR 2013 Guidelines for the characterisation of 
dispersion stability (Geneva: ISO) 13097:2013
	[109]	 Sawicki M, Stefanowicz W and Ney A 2011 Sensitive 
SQUID magnetometry for studying nano-magnetism 
Semicond. Sci. Technol. 26 64006
	[110]	 Wiekhorst F, Shevchenko E, Weller H and Kötzler J 2003 
Anisotropic superparamagnetism of monodispersive 
cobalt-platinum nanocrystals Phys. Rev. B 67 224416
	[111]	 Yasumori I, Reinen D and Selwood P W 1963 Anisotropic 
behavior in superparamagnetic systems J. Appl. Phys. 
34 3544
	[112]	 Hanson M et al 1993 The influence of magnetic anisotropy 
on the magnetization of small ferromagnetic particles 
J. Phys.: Condens. Matter 5 725–32
	[113]	 Faure B et al 2013 2D to 3D crossover of the magnetic 
properties in ordered arrays of iron oxide nanocrystals 
Nanoscale 5 953–60
	[114]	 Schaller V, Wahnström G, Sanz-Velasco A, Enoksson P 
and Johansson C 2009 Monte Carlo simulation of 
magnetic multi-core nanoparticles J. Magn. Magn. Mater. 
321 1400–3
	[115]	 Aquino R, Depeyrot J, Sousa M H, Tourinho F A, Dubois E 
and Perzynski R 2005 Magnetization temperature 
dependence and freezing of surface spins in magnetic 
fluids based on ferrite nanoparticles Phys. Rev. B  
72 184435
	[116]	 Mandal K, Mitra S and Kumar P A 2006 Deviation from 
Bloch T3/2 law in ferrite nanoparticles Eur. Lett. 
75 618–23
	[117]	 Tournus F and Tamion A 2011 Magnetic susceptibility curves 
of a nanoparticle assembly II. Simulation and analysis 
of ZFC/FC curves in the case of a magnetic anisotropy 
energy distribution J. Magn. Magn. Mater. 323 1118–27
	[118]	 Ludwig F, Guillaume A, Schilling M, Frickel N and 
Schmidt A M 2010 Determination of core and 
hydrodynamic size distributions of CoFe2O4 nanoparticle 
suspensions using ac susceptibility measurements J. Appl. 
Phys. 108 33918-1–5
	[119]	 Svedlindh P, Jonsson T and García-Palacios J L 1997 Intra-
potential-well contribution to the AC susceptibility of 
a noninteracting nano-sized magnetic particle system 
J. Magn. Magn. Mater. 169 323–34
	[120]	 Jonsson T, Mattsson J, Nordblad P and Svedlindh P 1997 
Energy barrier distribution of a noninteracting nano-
sized magnetic particle system J. Magn. Magn. Mater. 
168 269–77
	[121]	 Shliomis M I and Stepanov V I 1993 Frequency dependence 
and long time relaxation of the susceptibility of the 
magnetic fluids J. Magn. Magn. Mater. 122 176–81
	[122]	 Ahrentorp F et al 2010 Sensitive high frequency AC 
susceptometry in magnetic nanoparticle applications AIP 
Conf. Proc. 1311 213–23
	[123]	 Chemla Y R et al 2000 Ultrasensitive magnetic biosensor for 
homogeneous immunoassay Proc. Natl Acad. Sci. USA 
97 14268–72
	[124]	 Enpuku K, Minotani T, Hotta M and Nakahodo A 2001 
Application of high Tc SQUID magnetometer to biological 
immunoassays IEEE Trans. Appl. Supercond. 11 661–4
	[125]	 Grossman H L et al 2004 Detection of bacteria in suspension 
by using a superconducting quantum interference device 
Proc. Natl Acad. Sci. USA 101 129–34
	[126]	 Ludwig F, Heim E, Mauselein S, Eberbeck D and 
Schilling M 2005 Magnetorelaxometry of magnetic 
nanoparticles with fluxgate magnetometers for the analysis 
of biological targets J. Magn. Magn. Mater. 293 690–5
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
23
	[127]	 Ludwig F, Heim E and Schilling M 2007 Characterization 
of superparamagnetic nanoparticles by analyzing the 
magnetization and relaxation dynamics using fluxgate 
magnetometers J. Appl. Phys. 101 113909
	[128]	 Prieto Astalan A et al 2007 Magnetic response of thermally 
blocked magnetic nanoparticles in a pulsed magnetic field 
J. Magn. Magn. Mater. 311 166–70
	[129]	 Wiekhorst F, Steinhoff U, Eberbeck D and Trahms L 2012 
Magnetorelaxometry assisting biomedical applications of 
magnetic nanoparticles Pharm. Res. 29 1189–202
	[130]	 Keshoju K, Xing H and Sun L 2007 Magnetic field  
driven nanowire rotation in suspension Appl. Phys. Lett.  
91 123114
	[131]	 Dieckhoff J, Schilling M and Ludwig F 2011 Fluxgate based 
detection of magnetic nanoparticle dynamics in a rotating 
magnetic field Appl. Phys. Lett. 99 112501
	[132]	 Dieckhoff J, Schilling M and Ludwig F 2014 Magnetic 
marker based homogeneous bioassays utilizing rotating 
magnetic fields J. Appl. Phys. 115 17B304
	[133]	 Dieckhoff J, Lak A, Schilling M and Ludwig F 2014 Protein 
detection with magnetic nanoparticles in a rotating 
magnetic field J. Appl. Phys. 115 024701
	[134]	 Dieckhoff J H, Yoshida T, Enpuku K, Schilling M and 
Ludwig F 2012 Homogeneous bioassays based on the 
manipulation of magnetic nanoparticles by rotating and 
alternating magnetic fields: a comparison IEEE Trans. 
Magn. 48 3792–5
	[135]	 Wildeboer R R, Southern P and Pankhurst Q A 2014 On 
the reliable measurement of specific absorption rates 
and intrinsic loss parameters in magnetic hyperthermia 
materials J. Phys. D: Appl. Phys. 47 495003
	[136]	 Coïsson M et al 2016 Specific absorption rate determination 
of magnetic nanoparticles through hyperthermia 
measurements in non-adiabatic conditions J. Magn. Magn. 
Mater. 415 1–6
	[137]	 Kallumadil M, Tada M, Nakagawa T, Abe M, Southern P 
and Pankhurst Q A 2009 Suitability of commercial 
colloids for magnetic hyperthermia J. Magn. Magn. Mater. 
321 1509–13
	[138]	 Natividad E, Castro M and Mediano A 2009 Adiabatic versus 
non-adiabatic determination of specific absorption rate of 
ferrofluids, J. Magn. Magn. Mater. 321 1497–500
	[139]	 RadioMag 2015 www.cost-radiomag.eu/
	[140]	 Coïsson M, Barrera G, Celegato F, Martino L, Kane N S, 
Raghuvanshi S, Vinaj F and Tiberto P 2016 Hysteresis 
losses and specific absorption rate measurements in 
magnetic nanoparticles for hyperthermia applications 
Biochim. Biophys. Acta
	[141]	 Garaio E, Sandre O, Collantes J-M, Garcia J A, Mornet S 
and Plazaola F 2015 Specific absorption rate dependence 
on temperature in magnetic field hyperthermia measured 
by dynamic hysteresis losses (ac magnetometry) 
Nanotechnology 26 15704
	[142]	 Tóth É, Helm L and Merbach A E 2002 Relaxivity of MRI 
contrast agents Top. Curr. Chem. 221 61–101
	[143]	 Qiao R, Yang C and Gao M 2009 Superparamagnetic iron 
oxide nanoparticles: from preparations to in vivo MRI 
applications J. Mater. Chem. 19 6274
	[144]	 Shokrollahi H 2013 Contrast agents for MRI Mater. Sci. Eng. 
C 33 4485–97
	[145]	 Szpak A, Kania G, Skórka T, Tokarz W, Zapotoczny S 
and Nowakowska M 2013 Stable aqueous dispersion of 
superparamagnetic iron oxide nanoparticles protected by 
charged chitosan derivatives J. Nanopart. Res. 15 1372
	[146]	 Nordmeyer D et al 2014 Iron oxide nanoparticles stabilized 
with dendritic polyglycerols as selective MRI contrast 
agents Nanoscale 6 9646–54
	[147]	 Basini M, Orlando T, Arosio P, Casula F M, Espa D, 
Murgia S and Lascialfari A 2017 Local spin dynamics of 
iron oxide magnetic nanoparticles dispersed in different 
solvents with variable size and shape: a 1 H NMR study 
J. Chem. Phys. 146 034703
	[148]	 Ludwig F et al 2013 Characterization of magnetic 
nanoparticle systems with respect to their magnetic 
particle imaging performance Biomed. Tech. 58 535–45
	[149]	 Ludwig F et al 2014 Self-consistent magnetic properties of 
magnetite tracers optimized for magnetic particle imaging 
measured by AC susceptometry, magnetorelaxometry and 
magnetic particle spectroscopy J. Magn. Magn. Mater. 
360 169–73
	[150]	 Rauwerdink A M and Weaver J B 2010 Harmonic phase 
angle as a concentration-independent measure of 
nanoparticle dynamics Med. Phys. 37 2587–92
	[151]	 Schaller V et al 2008 Motion of nanometer sized magnetic 
particles in a magnetic field gradient J. Appl. Phys. 104 93918
	[152]	 Kerstin Witte C J, Müller K, Grüttner C and Westphal F 2016 
Particle size- and concentration-dependent separation of 
magnetic nanoparticles J. Magn. Magn. Mater.
	[153]	 Andreu J S, Camacho J, Faraudo J, Benelmekki M, 
Rebollo C and Martínez L M 2011 Simple analytical 
model for the magnetophoretic separation of 
superparamagnetic dispersions in a uniform magnetic 
gradient Phys. Rev. E 84 021402
	[154]	 CEN ISO/TS 13830 2013 Nanotechnologies—guidance 
on voluntary labelling for consumer products containing 
manufactured nano-objects
	[155]	 Regulation (EC) No 1272/2008 2008 Of the European 
Parliament and of the Council of 16 December 2008 on 
classification, labelling and packaging of substances and 
mixtures, amending and repealing Directives 67/548/EEC 
and 1999/45/EC, and amending Regulation (EC)
	[156]	 United Nations 2015 Globally Harmonized System of 
Classification and Labelling of Chemicals (GHS) (Rev.6)
	[157]	 ISO 2016 Medical devices—symbols to be used with medical 
device labels, labelling and information to be supplied 
(Geneva: ISO) 15223-1-2:2016
	[158]	 ISO 2009 In vitro diagnostic medical devices—information 
supplied by the manufacturer (labelling) (Geneva: ISO) 
18113-1-5:2009
	[159]	 Corot C, Robert P, Idée J M and Port M 2006 Recent 
advances in iron oxide nanocrystal technology for medical 
imaging Adv. Drug Deliv. Rev. 58 1471–504
	[160]	 Bin Na H, Song I C and Hyeon T 2009 Inorganic 
nanoparticles for MRI contrast agents Adv. Mater. 
21 2133–48
	[161]	 Wáng Y X and Idée J-M 2017 A comprehensive literatures 
update of clinical researches of superparamagnetic 
resonance iron oxide nanoparticles Magn. Reson. Imaging 
7 88–122
	[162]	 Suzuki Y et al 2008 In vivo serial evaluation of 
superparamagnetic iron-oxide labeled stem cells by off-
resonance positive contrast Magn. Reson. Med. 60 1269–75
	[163]	 Cunningham C H, Arai T, Yang P C, McConnell M V, 
Pauly J M and Conolly S M 2005 Positive contrast 
magnetic resonance imaging of cells labeled with 
magnetic nanoparticles Magn. Reson. Med. 53 999–1005
	[164]	 Senpan A et al 2009 Conquering the dark side: colloidal iron 
oxide nanoparticles ACS Nano 3 3917–26
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
24
	[165]	 ASTM 2013 Standard practice for marking medical 
devices and other items for safety in the magnetic 
resonance environment (West Conshohocken, PA: ASTM 
International) F2503-13
	[166]	 NEMA 2008 Characterization of the specific absorption 
rate (SAR) for magnetic resonance imaging systems MS 
8-2008
	[167]	 NEMA 2010 Acoustic noise measurement  procedure for 
diagnostic magnetic resonance imaging (MRI) devices  
MS 4-2010
	[168]	 NEMA 2008 Determination of signal to noise ration (SNR) 
in diagnostic magnetic resonance imaging MS 1-2008
	[169]	 NEMA 2008 Determination of signal to noise ration and 
image uniformity for single channel, non volume coils in 
diagnostic magnetic resonance imaging (MRI) MS 6-2008
	[170]	 NEMA 2009 Determination of slice thickness in diagnostic 
magnetic resonance imaging MS 5-2009
	[171]	 NEMA 2008 Determination of two dimensional geometric 
distortion in diagnostic magnetic resonance images MS 
2-2008
	[172]	 Busquets M A, Estelrich J and Sánchez-Martín M J 
2015 Nanoparticles in magnetic resonance imaging: 
from simple to dual contrast agents Int. J. Nanomed. 
10 1727–41
	[173]	 Tateo A et al 2016 Hybrid x-space: a new approach for MPI 
reconstruction Phys. Med. Biol. 61 4061–77
	[174]	 Goodwill P W and Conolly S M 2011 Multidimensional 
X-space magnetic particle imaging IEEE Trans. Med. 
Imaging 30 1581–90
	[175]	 Borgert J et al 2012 Fundamentals and applications of 
magnetic particle imaging J. Cardiovasc. Comput. Tomogr. 
6 149–53
	[176]	 Weizenecker J, Gleich B, Rahmer J, Dahnke H and Borgert J 
2009 Three-dimensional real-time in vivo magnetic 
particle imaging Phys. Med. Biol. 54 L1–10
	[177]	 Lüdtke-Buzug K et al 2013 Comparison of commercial iron 
oxide-based MRI contrast agents with synthesized high-
performance MPI tracers Biomed. Tech. 58 527–33
	[178]	 Ferguson R M, Khandhar A P and Krishnan K M 2012 
Tracer design for magnetic particle imaging (invited) 
J. Appl. Phys. 111 07B318
	[179]	 Ferguson R M et al 2015 Magnetic particle imaging with 
tailored iron oxide nanoparticle tracers IEEE Trans. Med. 
Imaging 34 1077–84
	[180]	 Panagiotopoulos N et al 2015 Magnetic particle imaging: 
current developments and future directions Int. J. 
Nanomed. 10 3097–114
	[181]	 Grüttner M et al 2013 On the formulation of the image 
reconstruction problem in magnetic particle imaging 
Biomed. Tech. 58 583–91
	[182]	 Rahmer J, Weizenecker J, Gleich B and Borgert J 2009 
Signal encoding in magnetic particle imaging: properties 
of the system function BMC Med. Imaging 9 4
	[183]	 Rahmer J and Weizenecker J 2012 Analysis of a 3-D system 
function measured for magnetic particle imaging IEEE 
Med. Imaging 31 1289–99
	[184]	 Lampe J et al 2012 Fast reconstruction in magnetic particle 
imaging Phys. Med. Biol. 57 1113–4
	[185]	 Schmidt D, Palmetshofer F, Heinke D, Gutkelch D, Radon P 
and Steinhoff U 2015 Characterizing the imaging 
performance of magnetic tracers by magnetic particle 
spectroscopy in an offset field Magnetic Particle Imaging 
(IWMPI), 2015 5th Int. Workshop on. IEEE (https://doi.
org/10.1109/IWMPI.2015.7107006)
	[186]	 Schmidt D, Graeser M, von Gladiss A, Buzug T M and 
Uwe S 2016 Imaging characterization of MPI tracers 
employing offset measurements in a two dimensional 
magnetic particle spectrometer Int. J. Magn. Part. Imaging
	[187]	 Arruebo M, Fernández-Pacheco R, Ibarra M R and 
Santamaría J 2007 Magnetic nanoparticles for drug 
delivery Nano Today 2 22–32
	[188]	 Veiseh O, Gunn J W and Zhang M 2010 Design and 
fabrication of magnetic nanoparticles for targeted drug 
delivery and imaging Adv. Drug Deliv. Rev. 62 284–304
	[189]	 McBain S C, Yiu H H P and Dobson J 2008 Magnetic 
nanoparticles for gene and drug delivery Int. J. Nanomed. 
3 169–80
	[190]	 Dobrovolskaia M A, Shurin M and Shvedova A A 
2016 Current understanding of interactions between 
nanoparticles and the immune system Toxicol. Appl. 
Pharmacol. 299 78–89
	[191]	 Zolnik B S, González-Fernández Á, Sadrieh N and 
Dobrovolskaia M A 2010 Minireview: nanoparticles and 
the immune system Endocrinology 151 458–65
	[192]	 Canesi L and Procházková P 2014 Nanoparticles and the 
Immune System (Atlanta, GA: Elsevier) ch 7 pp 91–112
	[193]	 Dattaa N R et al 2016 Magnetic nanoparticle-induced 
hyperthermia with appropriate payloads: Paul Ehrlich’s 
‘magic (nano)bullet’ for cancer theranostics? Cancer 
Treat. Rev. 50 217–27
	[194]	 Jordan A et al 2006 The effect of thermotherapy using 
magnetic nanoparticles on rat malignant glioma 
J. Neurooncol. 78 7–14
	[195]	 Johannsen M et al 2005 Clinical hyperthermia of prostate 
cancer using magnetic nanoparticles: presentation of a new 
interstitial technique Int. J. Hyperth. 21 637–47
	[196]	 Maier-Hauff K et al 2007 Intracranial thermotherapy using 
magnetic nanoparticles combined with external beam 
radiotherapy: results of a feasibility study on patients with 
glioblastoma multiforme J. Neurooncol. 81 53–60
	[197]	 Périgo E A et al 2015 Fundamentals and advances in 
magnetic hyperthermia Appl. Phys. Rev. 2 041302
	[198]	 BCC Research 2014 Cardiac Biomarkers: technologies and 
Global Markets vol BIO128A (Wellesley, MA: BCC 
Research)
	[199]	 Berensmeier S 2006 Magnetic particles for the separation and 
purification of nucleic acids Appl. Microbiol. Biotechnol. 
73 495–504
	[200]	 Šafarík I and Šafaríková M 1999 Use of magnetic techniques 
for the isolation of cells J. Chromatogr. B 722 33–53
	[201]	 Yavuz C T, Prakash A, Mayo J T and Colvin V L 2009 
Magnetic separations: From steel plants to biotechnology 
Chem. Eng. Sci. 64 2510–21
	[202]	 Yildiz I 2016 Applications of magnetic nanoparticles in 
biomedical separation and purification Nanotechnol. Rev. 
5 331
	[203]	 Rauwerdink A M and Weaver J B 2010 Measurement of 
molecular binding using the Brownian motion of magnetic 
nanoparticle probes Appl. Phys. Lett. 96 033702
	[204]	 Zhang X et al 2013 Molecular sensing with magnetic 
nanoparticles using magnetic spectroscopy of nanoparticle 
Brownian motion Biosens. Bioelectron. 50 441–6
	[205]	 Murase K, Song R and Hiratsuka S 2014 Magnetic 
particle imaging of blood coagulation Appl. Phys. Lett. 
104 252409
	[206]	 Elimelech M and Phillip W A 2011 The future of seawater 
desalination: energy, technology, and the environment 
Science 333 712–7
	[207]	 Ge Q, Su J, Chung T-S and Amy G 2011 Hydrophilic 
superparamagnetic nanoparticles: synthesis, 
characterization, and performance in forward osmosis 
processes Ind. Eng. Chem. Res. 50 382–8
	[208]	 Ling M M, Wang K Y and Chung T S 2010 Highly water-
soluble magnetic nanoparticles as novel draw solutes in 
forward osmosis for water reuse Ind. Eng. Chem. Res. 
49 5869–76
J. Phys. D: Appl. Phys. 50 (2017) 383003
Topical Review
25
	[209]	 Na Y, Yang S and Lee S 2014 Evaluation of citrate-coated 
magnetic nanoparticles as draw solute for forward osmosis 
Desalination 347 34–42
	[210]	Ling M M, Chung T-S and Lu X 2011 Facile synthesis of 
thermosensitive magnetic nanoparticles as ‘smart’ draw 
solutes in forward osmosis Chem. Commun. 47 10788–90
	[211]	 Zhou A, Luo H, Wang Q, Chen L, Zhang T C and Tao T 
2015 Magnetic thermoresponsive ionic nanogels as novel 
draw agents in forward osmosis RSC Adv. 5 15359–65
	[212]	 Chandra V, Park J, Chun Y, Lee J W, Hwang I C and 
Kim K S 2010 Water-dispersible magnetite-reduced 
graphene oxide composites for arsenic removal ACS Nano 
7 3979–86
	[213]	 Luo X, Wang C, Luo S, Dong R, Tu X and Zeng G 2012 
Adsorption of As (III) and As (V) from water using 
magnetite Fe3O4-reduced graphite oxide–MnO2 
nanocomposites Chem. Eng. J. 187 45–52
	[214]	 Zhu J et al 2012 Magnetic graphene nanoplatelet composites 
toward arsenic removal ECS J. Solid State Sci. Technol. 
1 M1–5
	[215]	 Wang H, Covarrubias J, Prock H, Wu X, Wang D and 
Bossmann S H 2015 Acid-functionalized magnetic 
nanoparticle as heterogeneous catalysts for biodiesel 
synthesis J. Phys. Chem. C 119 26020–8
	[216]	 Borbáth T, Bica D, Potencz I, Borbáth I, Boros T and 
Vékás L 2011 Leakage-free rotating seal systems with 
magnetic nanofluids and magnetic composite fluids 
designed for various applications Int. J. Fluid Mach. Syst. 
4 67–75
	[217]	 Borbáth T et al 2010 Magnetic nanofluids and magnetic 
composite fluids in rotating seal systems IOP Conf. Ser.: 
Earth Environ. Sci. 12 012015
	[218]	 Kumar D, Chandra P and Sinha P 1993 Ferrofluid lubrication 
of externally pressurised cirular plates and conical 
bearings Int. J. Eng. Sci. 31 593–604
	[219]	 Huang W and Wang X 2016 Ferrofluids lubrication: a status 
report Lubr. Sci. 28 3–26
	[220]	 Shah R C and Bhat M V 2002 Ferrofluid lubrication in 
porous inclined slider bearing with velocity slip Int. J. 
Mech. Sci. 44 2495–502
	[221]	 Brown P et al 2012 Magnetic control over liquid surface 
properties with responsive surfactants Angew. Chem., Int. 
Ed. 51 2414–6
	[222]	 ISO 2017 Nanotechnology—liquid suspension of magnetic 
nanoparticles—characteristics and measurements 19807
	[223]	 ISO N 2017 Nanotechnologies—specification for 
superparamagnetic beads composed of nanoparticles for 
circulating tumor DNA extraction 1421
J. Phys. D: Appl. Phys. 50 (2017) 383003
